WO1998000024A1 - Nutritional supplement composition and use - Google Patents
Nutritional supplement composition and use Download PDFInfo
- Publication number
- WO1998000024A1 WO1998000024A1 PCT/US1997/011243 US9711243W WO9800024A1 WO 1998000024 A1 WO1998000024 A1 WO 1998000024A1 US 9711243 W US9711243 W US 9711243W WO 9800024 A1 WO9800024 A1 WO 9800024A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- juice concentrate
- vitamin
- approx
- juice
- nutritional supplement
- Prior art date
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 63
- 239000000203 mixture Substances 0.000 title abstract description 122
- 235000021579 juice concentrates Nutrition 0.000 claims abstract description 208
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 96
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 96
- 229940088594 vitamin Drugs 0.000 claims abstract description 95
- 239000011782 vitamin Substances 0.000 claims abstract description 95
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 95
- 239000011719 vitamin A Substances 0.000 claims abstract description 95
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 91
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 50
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 50
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 46
- 239000011707 mineral Substances 0.000 claims abstract description 46
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 41
- 239000011669 selenium Substances 0.000 claims abstract description 41
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 41
- 235000011649 selenium Nutrition 0.000 claims abstract description 41
- 229930003231 vitamin Natural products 0.000 claims abstract description 37
- 235000013343 vitamin Nutrition 0.000 claims abstract description 37
- 239000009429 Ginkgo biloba extract Substances 0.000 claims abstract description 28
- 229940068052 ginkgo biloba extract Drugs 0.000 claims abstract description 28
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims abstract description 28
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 19
- 102000015779 HDL Lipoproteins Human genes 0.000 claims abstract description 16
- 108010010234 HDL Lipoproteins Proteins 0.000 claims abstract description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 14
- 239000008103 glucose Substances 0.000 claims abstract description 14
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 6
- 210000002381 plasma Anatomy 0.000 claims abstract 4
- 239000007937 lozenge Substances 0.000 claims description 99
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 76
- 235000008504 concentrate Nutrition 0.000 claims description 75
- 239000012141 concentrate Substances 0.000 claims description 75
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 70
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 56
- 239000011709 vitamin E Substances 0.000 claims description 45
- 235000019165 vitamin E Nutrition 0.000 claims description 45
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 44
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 42
- 239000011575 calcium Substances 0.000 claims description 42
- 229910052791 calcium Inorganic materials 0.000 claims description 42
- 235000001465 calcium Nutrition 0.000 claims description 42
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 41
- 235000019154 vitamin C Nutrition 0.000 claims description 41
- 239000011718 vitamin C Substances 0.000 claims description 41
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 40
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 40
- 229940045997 vitamin a Drugs 0.000 claims description 40
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 36
- 229930003427 Vitamin E Natural products 0.000 claims description 35
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 35
- 229940046009 vitamin E Drugs 0.000 claims description 35
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 34
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 33
- 229930003268 Vitamin C Natural products 0.000 claims description 33
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 32
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 30
- 240000007124 Brassica oleracea Species 0.000 claims description 30
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 30
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 28
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 28
- 229960000304 folic acid Drugs 0.000 claims description 28
- 235000019152 folic acid Nutrition 0.000 claims description 28
- 239000011724 folic acid Substances 0.000 claims description 28
- 239000011777 magnesium Substances 0.000 claims description 28
- 229910052749 magnesium Inorganic materials 0.000 claims description 28
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 27
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 23
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 23
- 235000009467 Carica papaya Nutrition 0.000 claims description 23
- 244000019459 Cynara cardunculus Species 0.000 claims description 23
- 235000019106 Cynara scolymus Nutrition 0.000 claims description 23
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 23
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 23
- 235000016520 artichoke thistle Nutrition 0.000 claims description 23
- 235000011197 perejil Nutrition 0.000 claims description 23
- 239000011701 zinc Substances 0.000 claims description 23
- 229910052725 zinc Inorganic materials 0.000 claims description 23
- 229910052742 iron Inorganic materials 0.000 claims description 22
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 19
- 239000008280 blood Substances 0.000 claims description 19
- 235000020384 spinach juice Nutrition 0.000 claims description 19
- 235000013948 strawberry juice Nutrition 0.000 claims description 19
- 235000019157 thiamine Nutrition 0.000 claims description 19
- 229960003495 thiamine Drugs 0.000 claims description 19
- 239000011721 thiamine Substances 0.000 claims description 19
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 18
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 18
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 18
- 235000015190 carrot juice Nutrition 0.000 claims description 18
- 229910052802 copper Inorganic materials 0.000 claims description 18
- 239000010949 copper Substances 0.000 claims description 18
- 229960003512 nicotinic acid Drugs 0.000 claims description 18
- 235000001968 nicotinic acid Nutrition 0.000 claims description 18
- 239000011664 nicotinic acid Substances 0.000 claims description 18
- 235000019192 riboflavin Nutrition 0.000 claims description 18
- 229960002477 riboflavin Drugs 0.000 claims description 18
- 239000002151 riboflavin Substances 0.000 claims description 18
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 17
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 claims description 17
- 229940055726 pantothenic acid Drugs 0.000 claims description 17
- 239000011713 pantothenic acid Substances 0.000 claims description 17
- 235000019161 pantothenic acid Nutrition 0.000 claims description 17
- 229960002685 biotin Drugs 0.000 claims description 15
- 239000011616 biotin Substances 0.000 claims description 15
- 235000020958 biotin Nutrition 0.000 claims description 15
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 13
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 13
- 235000016709 nutrition Nutrition 0.000 claims description 13
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims description 12
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 12
- 244000194101 Ginkgo biloba Species 0.000 claims description 12
- 241000219173 Carica Species 0.000 claims description 11
- 241000219823 Medicago Species 0.000 claims description 11
- 241000208317 Petroselinum Species 0.000 claims description 11
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 10
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 10
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 10
- 239000011572 manganese Substances 0.000 claims description 10
- 229910052748 manganese Inorganic materials 0.000 claims description 10
- 235000015197 apple juice Nutrition 0.000 claims description 9
- 229940069780 barley extract Drugs 0.000 claims description 9
- 230000035764 nutrition Effects 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 240000007087 Apium graveolens Species 0.000 claims description 7
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 7
- 235000010591 Appio Nutrition 0.000 claims description 7
- 235000009364 Cucurbita pepo var ovifera Nutrition 0.000 claims description 7
- 244000008210 Cucurbita pepo var. ovifera Species 0.000 claims description 7
- 240000008415 Lactuca sativa Species 0.000 claims description 7
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 7
- 244000298697 Actinidia deliciosa Species 0.000 claims description 6
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 240000005561 Musa balbisiana Species 0.000 claims description 6
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 235000015193 tomato juice Nutrition 0.000 claims description 6
- 235000019166 vitamin D Nutrition 0.000 claims description 6
- 239000011710 vitamin D Substances 0.000 claims description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 6
- 229940046008 vitamin d Drugs 0.000 claims description 6
- 235000005254 Allium ampeloprasum Nutrition 0.000 claims description 5
- 240000006108 Allium ampeloprasum Species 0.000 claims description 5
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 5
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 5
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 5
- 244000064816 Brassica oleracea var. acephala Species 0.000 claims description 5
- 235000021538 Chard Nutrition 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 5
- 244000241257 Cucumis melo Species 0.000 claims description 5
- 235000009847 Cucumis melo var cantalupensis Nutrition 0.000 claims description 5
- 235000002767 Daucus carota Nutrition 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 5
- 244000017020 Ipomoea batatas Species 0.000 claims description 5
- 235000002678 Ipomoea batatas Nutrition 0.000 claims description 5
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 5
- 244000025272 Persea americana Species 0.000 claims description 5
- 235000008673 Persea americana Nutrition 0.000 claims description 5
- 244000141353 Prunus domestica Species 0.000 claims description 5
- 244000061456 Solanum tuberosum Species 0.000 claims description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 5
- 229910052804 chromium Inorganic materials 0.000 claims description 5
- 239000011651 chromium Substances 0.000 claims description 5
- 235000021384 green leafy vegetables Nutrition 0.000 claims description 5
- 229910052750 molybdenum Inorganic materials 0.000 claims description 5
- 239000011733 molybdenum Substances 0.000 claims description 5
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 claims description 4
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 claims description 4
- 240000000560 Citrus x paradisi Species 0.000 claims description 4
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 4
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 4
- 235000011430 Malus pumila Nutrition 0.000 claims description 4
- 235000015103 Malus silvestris Nutrition 0.000 claims description 4
- 241000219315 Spinacia Species 0.000 claims description 4
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 4
- 235000021015 bananas Nutrition 0.000 claims description 4
- 235000021329 brown rice Nutrition 0.000 claims description 4
- 240000009088 Fragaria x ananassa Species 0.000 claims description 3
- 241000220225 Malus Species 0.000 claims description 3
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 230000003247 decreasing effect Effects 0.000 claims description 3
- 235000015201 grapefruit juice Nutrition 0.000 claims description 3
- 235000009434 Actinidia chinensis Nutrition 0.000 claims description 2
- 235000011201 Ginkgo Nutrition 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 235000015205 orange juice Nutrition 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 4
- 244000291564 Allium cepa Species 0.000 claims 2
- 235000006486 human diet Nutrition 0.000 abstract description 34
- 229940098465 tincture Drugs 0.000 abstract description 3
- 229910052700 potassium Inorganic materials 0.000 description 36
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 31
- 239000011591 potassium Substances 0.000 description 31
- 235000007686 potassium Nutrition 0.000 description 31
- 239000013589 supplement Substances 0.000 description 31
- 150000001875 compounds Chemical class 0.000 description 30
- 235000010755 mineral Nutrition 0.000 description 29
- 239000004615 ingredient Substances 0.000 description 19
- 210000002966 serum Anatomy 0.000 description 18
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 16
- 239000011574 phosphorus Substances 0.000 description 16
- 229910052698 phosphorus Inorganic materials 0.000 description 16
- 229940068196 placebo Drugs 0.000 description 15
- 239000000902 placebo Substances 0.000 description 15
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 13
- 239000011648 beta-carotene Substances 0.000 description 13
- 235000013734 beta-carotene Nutrition 0.000 description 13
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 13
- 229960002747 betacarotene Drugs 0.000 description 13
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 13
- 240000006432 Carica papaya Species 0.000 description 12
- 240000004658 Medicago sativa Species 0.000 description 12
- 240000009164 Petroselinum crispum Species 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- 229960005069 calcium Drugs 0.000 description 10
- -1 green barley extract Substances 0.000 description 10
- 229960003284 iron Drugs 0.000 description 10
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 9
- 229960003966 nicotinamide Drugs 0.000 description 9
- 235000005152 nicotinamide Nutrition 0.000 description 9
- 239000011570 nicotinamide Substances 0.000 description 9
- 239000007800 oxidant agent Substances 0.000 description 9
- 102000019197 Superoxide Dismutase Human genes 0.000 description 8
- 108010012715 Superoxide dismutase Proteins 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 229940108928 copper Drugs 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 229940091250 magnesium supplement Drugs 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 108010007622 LDL Lipoproteins Proteins 0.000 description 5
- 102000007330 LDL Lipoproteins Human genes 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 229960005070 ascorbic acid Drugs 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 229960003975 potassium Drugs 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229940083542 sodium Drugs 0.000 description 5
- 235000015424 sodium Nutrition 0.000 description 5
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
- 108010003541 Platelet Activating Factor Proteins 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000008821 health effect Effects 0.000 description 4
- 239000011630 iodine Substances 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 241000234282 Allium Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 240000003978 Ipomoea coccinea Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000006993 memory improvement Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- UVZCKRKEVWSRGT-UHFFFAOYSA-N chromium(ii) selenide Chemical compound [Se]=[Cr] UVZCKRKEVWSRGT-UHFFFAOYSA-N 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 229940063755 folic acid 0.1 mg Drugs 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- SQOJOAFXDQDRGF-WJHVHIKBSA-N ginkgolide B Natural products O=C1[C@@H](C)[C@@]2(O)[C@@H]([C@H](O)[C@]34[C@@H]5OC(=O)[C@]23O[C@H]2OC(=O)[C@H](O)[C@@]42[C@H](C(C)(C)C)C5)O1 SQOJOAFXDQDRGF-WJHVHIKBSA-N 0.000 description 2
- SQOJOAFXDQDRGF-MMQTXUMRSA-N ginkgolide-b Chemical compound O[C@H]([C@]12[C@H](C(C)(C)C)C[C@H]3OC4=O)C(=O)O[C@H]2O[C@]24[C@@]13[C@@H](O)[C@@H]1OC(=O)[C@@H](C)[C@]21O SQOJOAFXDQDRGF-MMQTXUMRSA-N 0.000 description 2
- 230000005802 health problem Effects 0.000 description 2
- 235000013666 improved nutrition Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- BUGBHKTXTAQXES-DBXDQKISSA-N selenium-70 Chemical compound [70Se] BUGBHKTXTAQXES-DBXDQKISSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- YPFNIPKMNMDDDB-UHFFFAOYSA-K 2-[2-[bis(carboxylatomethyl)amino]ethyl-(2-hydroxyethyl)amino]acetate;iron(3+) Chemical compound [Fe+3].OCCN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O YPFNIPKMNMDDDB-UHFFFAOYSA-K 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008334 Cervicobrachial syndrome Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 241001417524 Pomacanthidae Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- OXYOQBAZFDHPBM-UHFFFAOYSA-N [P].[Se] Chemical compound [P].[Se] OXYOQBAZFDHPBM-UHFFFAOYSA-N 0.000 description 1
- XYUNNDAEUQFHGV-UHFFFAOYSA-N [Se].[Se] Chemical compound [Se].[Se] XYUNNDAEUQFHGV-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000009285 allergic inflammation Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940054666 biotin 0.15 mg Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229940090568 combinations of vitamin Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229940036630 folic acid 0.2 mg Drugs 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 229940083591 ginkgo biloba extract 60 mg Drugs 0.000 description 1
- 239000003979 granulating agent Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 230000010370 hearing loss Effects 0.000 description 1
- 231100000888 hearing loss Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004066 metabolic change Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229940030033 niacin 15 mg Drugs 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940088197 riboflavin 3 mg Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 238000012762 unpaired Student’s t-test Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to nutritional supplements to the human diet, and more specifically to nutritional supplements which contain a combination of naturally occurring substances such as vitamins and minerals, antioxidants , green barley extract, and ginkgo biloba extract.
- uar ⁇ iovascuiar ⁇ isease resulting from the buildup of arterial plaque is a leading cause of illness or death.
- Arterial plaque is precipitous material formed chiefly of oxidized low density lipoprotein (0-LDL) .
- the buildup of plaque in the form of O-LDL in the arteries is understood to be a factor in ischaemic heart disease.
- Free radical oxidants many of which come from naturally occurring sources such as sun exposure, metabolism of certain nutrients, and exercise, act to oxidize low density lipoprotein (LDL) into its deleterious form, 0-LDL.
- HDL high density lipoprotein
- antioxidants are chemicals that react with free radicals, such as hydroxy radical, to protect certain biological systems.
- free radicals such as hydroxy radical
- SOD superoxide dismutase
- carotenoids carotenoids
- alpha- tocopherol alpha- tocopherol
- uric acid is suggested to have a positive correlation with resistance to spontaneous autoxidation of tissues and oxidative damage to DNA in mammals [Cutler, R., Am. J. Clin. Nutr. , 5J3.373S-9S (1991)].
- Antioxidants are also known to limit destruction of healing brain tissue by free radicals as shown by the method for resuscitating the brain using vitamins such as A, E and C or selenium [See, Klatz et al . , U.S. Patent No. 5,149,321 and PCT application PCT/US92/06681] .
- vitamins A, C, and E are well known to have other beneficial health effects.
- vitamin E is known to help maintain proper blood sugar levels.
- vitamin C is known to play an integral role in the integrity of connective and structural tissues in the body.
- Vitamin A is known to play a role in maintaining good vision as well as in growth and development. Hence, an adequate supply of these vitamins is essential in maintaining optimum health.
- the use of vitamins A, E, C and selenium has been proposed as a means to inhibit or prevent collagen cross-linking in human skin when used in combination with certain active peptides [See, Geoffrey et al . , PCT application WO 90/06102] .
- Green barley is known to be a rich source of highly metabolizable vitamins and minerals such as vitamins A, Bl , B2 , B6, and C, potassium, magnesium, and zinc.
- green barley also has a high concentration of the enzyme superoxide dismutase (SOD) , which has been shown to have high levels of antioxidant activity.
- SOD superoxide dismutase
- Green barley is believed to be an important nutrient in the regulation of the digestive process because the micronutrients, enzymes (e.g., SOD), and fiber contained in green barley are believed to improve intestinal function [D. Walsh et al . , British J. Nutr .. 70:621-630 (1993) ] .
- Ginkgo biloba has been a staple Chinese herbal ingredient for thousands of years, and is frequently recommended by Chinese herbal practitioners for coughs, asthma and acute allergic inflammations.
- active organic compounds in ginkgo biloba including Ginkgolide B which has been shown to be an active constituent and which apparently works by interfering with platelet activating factor (PAF) .
- PAF platelet activating factor
- PAF is known to have several biological functions, including induction of platelet aggregation, neutrophil degranulation and oxygen radical production, and increasing microvascular permeability and bronchoconstriction. It has been shown that by its inhibitory interaction with PAF, Ginkgolide B helps improve cerebral metabolism and protect the brain against hypoxic damage in laboratory animals with cerebral ischaemia [Kleijnen, J.
- ginkgo biloba extract is licensed in Germany for the treatment of cerebral dysfunction, hearing loss resulting from cervical syndrome, and peripheral arterial circulatory disturbances with intact circulatory reserve (intermittent claudication) [See, Kleijnen, J. and Knipschild, P., cited above] .
- Other studies indicate the efficacy of using ginkgo biloba extract to improve mental acuity [See, e.g., Nutrition Today, July/August : 11-18 (1988); Ginkgo Biloba Extract in Perspective, Auckland, New Zealand: ADIS Press Limited: Iff (1990) ] .
- a healthy balance of vitamins and minerals has been known to be critical to sustain a healthy human body. Many combinations of vitamins and minerals have been taught over the years as food supplements beneficial to a human health, and the daily ingestion of fruits and vegetables has long been recognized as critical to a healthy diet .
- compositions of the present invention are novel combinations of selected ingredients that are known to benefit the human organism. More particularly, a first class of nutritional supplements of the present invention provides a novel combination of: (1) a specific antioxidant component; (2) a specific green barley component; (3) a specific vitamin and mineral component, and (4) a particular tincture of ginkgo biloba extract, the combination of which provides for improved nutrition when ingested by humans. A second class of nutritional supplements of the present invention provides a novel combination of ingredients of the antioxidant component, the combination of which provides for improved nutrition when ingested by humans .
- the present invention also teaches the use of these compositions to supplement the human diet. Therefore, it is an object of the invention to provide novel a method of supplementing the human diet using the dietary supplements taught herein.
- the present invention provides for methods to maintain proper glucose levels in blood serum using the novel nutritional supplements of the invention.
- Another object of the present invention is to increase levels of minerals such as calcium in human blood serum and tissues using the novel nutritional supplements of the present invention.
- Another object of the present invention is to increase levels of vitamins such as vitamins A and E and other nutrients such as beta-carotene in human blood serum and tissues using the novel nutritional supplements of the present invention .
- the present invention provides methods for reducing the risk of the harmful biological effects of free radicals and other oxidants in the human system.
- the present invention provides novel nutritional supplements used to effect memory enhancement .
- novel nutritional compositions of the present invention significantly improve the general metabolic, circulatory and nervous systems of the human body, and thus help overcome, or diminish the effect of many of the metabolic problems that occur with the aging of the human system.
- the present compositions are novel combinations of naturally occurring substances, are non-toxic when administered according to the methods of the present invention, and provide for a more complete nutritional regime.
- the present invention focuses on the development and maintenance of vitality and fortitude of the human body as a direct result of the daily oral intake of the compositions of the present invention.
- the aim of the present invention is to provide compositions that act on the human systems to safely reduce the risks of health problems arising from the presence of oxidants in the human blood and tissues, from low glucose levels in blood serum, and from inadequately low levels of minerals such as calcium in the human blood serum and tissues Helping avoid the harmful biological effects of free radicals m the human system, namely inflammation, collagen degradation, and cardiovascular disease, among others, is a prime objective of the present invention.
- the present invention also provides a composition and method that may maintain proper blood sugar levels and effect memory enhancement .
- Some of the observable metabolic changes effected as a direct result of administering the compositions of the present invention are significant, and include: (a) a significant lowering of the blood sugar level; (b) an increase in the concentration of high density lipid protein (HDL) in the blood serum; (c) an increase m blood serum calcium levels, and (d) an increase in blood serum levels of nutrients known to improve human health such as vitamins A and E, and beta- carotene.
- HDL high density lipid protein
- compositions of the invention show evidence of the effect of the compositions of the invention on calcium ion concentrations and blood glucose levels.
- a normal blood glucose level is approximately 100 g/dl . It is generally understood that persons having a blood glucose level of between 100 mg/dl and 150 mg/dl have above-normal levels, and individuals having a blood glucose level of greater than 150 mg/dl are considered diabetic. Since the compositions of the present invention are able to cause an approximate 22% decrease in the level of blood glucose, individuals who have above normal levels of blood glucose may have their levels reduced to normal levels upon administration of the compositions of the present invention.
- compositions of the present invention are also believed to have an effect on memory enhancement because they contain ginkgo, a substance known to have an effect on persons suffering from difficulties of concentration and memory, absent mindedness, confusion, and headaches [See, Kleijnen, J. and Knipschild, P., cited above].
- compositions of the present invention represent a combination of nutritive food supplements that work together with various metabolic systems of the human body.
- Each composition in a first class of novel nutritional supplement compositions contains at least one of each of the following four components: (1) a compendial grade multi -vitamin and mineral dietary supplement, where a primary source of the vitamins is from specific combinations of food concentrates; (2) a green barley extract; (3) a compendial grade of a specified combination of antioxidant vitamins A, C, E, and selenium, where the primary source of the antioxidants arises from selected food concentrates which may or may not be the same as the selected food concentrates of the multi -vitamin and mineral component; and (4) a ginkgo biloba extract.
- the first class of compositions of the present invention can be administered as: (1) a dosage comprising multiple lozenges of separate and distinct components (e.g., a green barley extract component, an antioxidant component, a multi-vitamin and mineral component, and a ginkgo biloba extract component), or, more preferably; (2) a dosage comprising multiple lozenges, each of the same composition, where the four components are combined into a single lozenge; or (3) other dosage forms known in the art.
- a dosage comprising multiple lozenges of separate and distinct components e.g., a green barley extract component, an antioxidant component, a multi-vitamin and mineral component, and a ginkgo biloba extract component
- a dosage comprising multiple lozenges each of the same composition, where the four components are combined into a single lozenge
- Each of the vitamins and minerals as well as the ginkgo biloba and green barley extracts of the components are commercially available, and can be blended to form a single composition or can form multiple compositions which
- Vitamins A, Bl, B2 , B6 Vitamins A, C C, Niacinamide, Pantothenic acid, Folic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc
- Grapefruit Vitamins A and C Vitamins A, C Calcium, Phosphorus, Iron, Potassium, Sodium, Thiamine, Riboflavin, Niacin, Ascorbic acid
- Vitamins A, Bl, B2 , B6 Vitamins A, C C, Niacinamide, Pantothenic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc
- Vitamins A, Bl, B2 , B6 Vitamins, A, C C, Niacinamide, Pantothenic acid, Folic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc, Para ammobenzoic acid (PABA)
- Vitamins A, Bl, B2 , B6 Vitamins A, C, E C, E, Niacinamide, Pantothenic acid, Folic acid. Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc
- Vitamins Bl Sweet Potato Potassium, Vitamins Bl, Vitamin C, Selenium B2, C, Folic acid, Phosphorus, Selenium, Calcium Swiss Chard Potassium, Magnesium, Vitamins A, C Calcium, Vitamins A, C
- Tomato Potassium Magnesium, Vitamins A, c, Calcium, Nickel, Selenium Chromium, Phosphorus, Boron, Selenium, Vitamins A, C, K, Bl, B2, Folic acid
- a dosage of the antioxidant component of the first class of nutritional supplement compositions of the present invention may consist of two lozenges for human oral consumption.
- the preferred weight of each of the antioxidant lozenges is between about 1,000 mg to about 2000 mg, and preferably about 1,500 mg.
- the total weight of one dosage of the antioxidant component of the present invention is between about 2,000 mg and about 4,000 mg, and most preferably about 3,000 mg .
- the antioxidant lozenge comprises vitamins A, E, C, and selenium, and at least one juice concentrate, selected from the plurality of juice concentrates including acorn squash, alfalfa, apple, artichoke, avocado, bananas, broccoli, brussels sprouts, cabbage, cantaloupe, carrot, cauliflower, celery, collard greens, grapefruit, green leek, green barley, kale, kiwi fruit, lettuce, onion, papaya, parsley, potato, prune, spinach, strawberry, sweet potato, swiss chard, and tomato juice concentrates.
- juice concentrates including acorn squash, alfalfa, apple, artichoke, avocado, bananas, broccoli, brussels sprouts, cabbage, cantaloupe, carrot, cauliflower, celery, collard greens, grapefruit, green leek, green barley, kale, kiwi fruit, lettuce, onion, papaya, parsley, potato, prune, spinach, strawberry, sweet potato, swiss chard
- the total weight of the combination of vitamin C, vitamin A, vitamin E, and selenium in the antioxidant component of the present invention is about 10% to about 50% of the total weight of the antioxidant lozenge, preferably about 15% to about 30% of the total weight of the antioxidant lozenge and most preferably about 20% of the total weight of the antioxidant lozenge.
- a suitable antioxidant component consistent with the present invention comprises about 5,000 IU to about 20,000 IU of vitamin A, more preferably about 7,500 IU to about 15,000 IU and most preferably about 9,000 IU to about 10,000 IU of vitamin A (in the form of beta-carotene) per dose.
- a compendial grade of vitamin C can be employed in the antioxidant component of the present composition.
- the antioxidant component comprises, by weight percent, about 200 mg to about 2,000 mg of vitamin C, preferably about 300 mg to about 1,000 mg of vitamin C and most preferably about 450 mg to about 550 mg per dose.
- a compendial grade of vitamin E can also be employed in the antioxidant component of the present composition.
- the antioxidant component comprises about 100 IU to about 500 IU of vitamin E, preferably about 175 IU to about 425 IU of vitamin E, and most preferably about 190 IU to about 225 IU of vitamin E per dose.
- a compendial grade of selenium can be incorporated in the antioxidant component of the present invention.
- the antioxidant component of the present invention comprises, by weight, about 50 micrograms to about 200 micrograms of selenium, preferably about 75 micrograms to about 150 micrograms, and most preferably about 100 micrograms of selenium per dose .
- the total weight of the juice concentrates in the preferred embodiment of the antioxidant component of the present invention is about 30 to about 80% of the total weight of the antioxidant lozenge, and most preferably about 60% of the weight of the antioxidant lozenge.
- a suitable composition consistent with the present invention comprises juice concentrates having a concentration of at least 10 times that of the native juice in the unconcentrated form, and preferably about 15 times more concentrated, and most preferably about 20 times more concentrated than the unconcentrated juice.
- the juice concentrates are essentially anhydrous, and are generally in powder form.
- a form of acorn squash suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of alfalfa juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about
- a form of apple juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about
- a form of artichoke juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
- a form of avocado juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention.
- a form of banana juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention.
- a form of broccoli juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention .
- a form of brussels sprout juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention .
- a form of cabbage juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 1% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
- a form of cantaloupe juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of carrot juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of cauliflower juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of celery juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of collard greens juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 1% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
- a form of grapefruit juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
- a form of green leek juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
- a form of green barley juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of kale juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention.
- a form of kiwi fruit juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention.
- a form of lettuce juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention.
- a form of onion juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 5% of the weight of the juice concentrate composition of the present invention.
- a form of papaya juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of parsley juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about
- a form of potato juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of prune juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of spinach juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
- a form of strawberry juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 7.5% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
- a form of sweet potato juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
- a form of swiss chard juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 7.5% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
- a form of tomato juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 1% to about 10% of the weight of the total uice concentrate compound of the present invention, and most preferably about 3% of the weight of the juice concentrate composition of the present invention.
- the multi -vitamin and mineral component of the first class of compositions of the present invention consists of two multi -vitamin and mineral lozenges for human oral consumption taken twice daily (total of four lozenges per day -- i.e., two doses per day) .
- the preferred weight of each of the lozenges is between about 750 mg to about 1,500 mg, preferably about 1,000 mg .
- the total weight of one dosage of the vitamm-mmeral component of the present invention is between about 1,500 mg and about 3,000 mg and most preferably about 2,000 mg .
- the multi-vitamin and mineral component of the first class of compositions of the invention may be comprised of juice concentrates -- the total weight of which is about 4% to about 25% the total weight of the multi-vitamin and mineral lozenge, and most preferably about 12% of the weight of the multi-vitamin and mineral lozenge.
- the total weight of the juice concentrate is about 3% to about 50%, and most preferably about 5% to about 35% of the total weight of the lozenge.
- the total weight of the combination of non-juice concentrate-derived vitamins and minerals in the multi -vitamin component of the first class of compositions of the present invention is about 10% to about 90% of the total weight of the multi-vitamin and mineral lozenge, preferably about 15% to about 80% of the total weight of the multi -vitamin and mineral lozenge and most preferably about 65% of the total weight of the multi -vitamin and mineral lozenge.
- a suitable multi-vitamin and mineral component of the first class of compositions of the present invention comprises about 1,000 IU to about 10,000 IU of vitamin A, more preferably about 1,500 IU to about 4,500 IU and most preferably about 3,500 IU of vitamin A (in the form of beta-carotene) per lozenge.
- Vitamin A may be contributed by the juice concentrates as described above, or it may be contributed in non-juice form.
- a compendial grade of vitamin C can be employed in the multi -vitamin composition.
- Each lozenge of the multi-vitamin component of the first class of compositions of the present invention comprises, by weight, about 10 mg to about 200 mg of vitamin C, preferably about 15 mg to about 175 mg of vitamin C and most preferably about 125 mg per lozenge.
- Vitamin C may be contributed by the juice concentrates as described above, or it may be contributed in non-juice form.
- a suitable multi -vitamin component of the first class of compositions of the present invention comprises about 10 IU to about 1,000 IU of vitamin D, more preferably about 15 IU to about 350 IU and most preferably about 100 IU of vitamin D per lozenge.
- a suitable multi-vitamin component of the first class of compositions of the present invention comprises about 5 IU to about 50 IU of vitamin E, more preferably about 5 IU to about 35 IU and most preferably about 11.5 IU of vitamin E per lozenge.
- Vitamin E may be contributed by the juice concentrates as described above, or it may be contributed in non-juice form.
- a compendial grade of folic acid or folic acid salt may be employed in the multi -vitamin component.
- Each lozenge of the multi-vitamin component of the present invention comprises, by weight, about 0.03 mg to about 1 mg of folic acid, preferably about 0.04 mg to about 0.06 mg of folic acid, and most preferably about 0.05 mg of folic acid per lozenge .
- a compendial grade of thiamine (B-l) may be employed in the multi-vitamin component.
- Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 0.01 mg to about 1.0 mg of thiamine (B-l), preferably about 0.15 mg to about 0.75 mg of thiamine (B-l) and most preferably about 0.5 mg of thiamine (B-l) per lozenge.
- a compendial grade of riboflavin may be employed in the multi-vitamin composition.
- Each lozenge of the multi-vitamin composition of the present invention comprises, by weight, about 0.01 mg to about 5.0 mg of riboflavin, preferably about 0.15 mg to about 2.75 mg of riboflavin and most preferably about 0.5 mg of riboflavin per lozenge .
- a compendial grade of niacin may be employed in the multi -vitamin component.
- Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 1.0 mg to about 100 mg of niacin, preferably about 0.5 mg to about 10 mg of niacin and most preferably about 7.5 mg of niacin per lozenge.
- a compendial grade of vitamin B-6 may be employed in the multi -vitamin component.
- Each lozenge of the multi-vitamin component of the present invention comprises, by weight, about 1.0 mg to about 10.0 mg of vitamin B-6, preferably about 1.5 mg to about 7.5 mg of vitamin B-6 and most preferably about 1.125 mg of vitamin B-6.
- a compendial grade of vitamin B-12 may be employed in the multi-vitamin component.
- Each lozenge of the multi-vitamin component of the present invention comprises, by weight, about 1.0 mg to about 10.0 mg of vitamin B-12, preferably about 1.5 mg to about 7.5 mg of vitamin B-12 and most preferably about 2.25 mg of vitamin B- 12.
- a compendial grade of biotin may be employed in the multi-vitamin component.
- Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 0.10 mg to about 1.00 mg of biotin, preferably about 0.15 mg to about 0.95 mg of biotin and most preferably about 0.75 mg of biotin.
- a compendial grade of zinc may be employed the multi -vitamin component.
- Each lozenge of the multi-vitamin component of the present invention comprises, by weight, about 1.0 mg to about 10.0 mg of zinc, preferably about 1.5 mg to about 7.5 mg of zinc and most preferably about 5.0 mg of zinc.
- a compendial grade of manganese may be employed in the multi-vitamin component.
- Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 1.0 mg to about 10.0 mg of manganese, preferably about 1.15 mg to about 1.75 mg of manganese and most preferably about 1.25 mg of manganese.
- a compendial grade of selenium may be employed in the multi-vitamin component.
- Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 5 micrograms to about 20 micrograms of selenium, preferably about 7.5 micrograms of selenium.
- a suitable multi -vitamin and mineral component of the first class of compositions of the present invention optionally comprises juice concentrates having a concentration of at least 10 times that of the native juice in the unconcentrated form, and preferably about 15 times more concentrated, and most preferably about 20 times more concentrated than the unconcentrated juice.
- the juice concentrates are essentially anhydrous, are generally in powder form, and may be selected from the juice concentrates of the antioxidant component.
- the green barley component of the first class of compositions of the present invention comprises, by weight percent, about 60% to about 90%, and most preferably about 80% green barley juice concentrate [Westar
- a preferred green barley preparation of the present invention consists of one lozenge (one dose) twice per day for human consumption.
- a preferred weight of the green barley lozenge is from about 600 mg to about 1,000 mg and most preferably about 750 mg .
- This green barley component of the first class of compositions of the compositions of the present invention is a separate required component from the green barley juice concentrate that may exist as part of the antioxidant preparation. This green barley component, although separate and required, may take the same form as that described in the antioxidant section above.
- the ginkgo biloba extract component of the first class of compositions of the present invention consists of about 5% to about 35% and most preferably from about 10% to about 15% ginkgo biloba extract [Westar Nutrition, Inc.] .
- a preferred dosage of the ginkgo biloba extract component of the present invention consists of one lozenge twice a day for human consumption.
- a preferred weight of the lozenge is from about 400 mg to about 750 mg, and most preferably 500 mg .
- a preferred dosage of the first class of compositions of the present invention may consist of six lozenges for human oral consumption -- two antioxidant lozenges, two vitamin and mineral lozenges, and one of each of the ginkgo biloba extract and green barley extract lozenges.
- the preferred weight of each of the antioxidant and vitamin and mineral lozenges is between about 1,000 mg to about 2,000 mg, preferably about 1,500 mg.
- the preferred weight of the green barley lozenge is about 600 mg to about 1,000 mg, and preferably about 750 mg .
- the preferred weight of the ginkgo biloba lozenge is about 400 mg to about 750 mg, and most preferably about 500 mg .
- the total weight of one dosage of the first class of compositions of the present invention is between 6,000 mg and 12,000 mg and most preferably about 9,000 mg .
- the components of the first class of compositions of the present invention may be combined into fewer than six lozenges to give the appropriate amounts of each component.
- a dosage is administered twice daily.
- Second Class of Nutritional Supplements In a second class of compositions of the present invention, select moieties of the antioxidant component of the first class of compositions of the present invention may provide for many of the beneficial health effects described above. Specifically, the second class of compositions may consist of two lozenges for human oral consumption. The second class of compositions of the present invention falls within the description of the antioxidant component of the first class of compositions described above, but it is as specific combination of the ingredients of that component. More specifically, the second class of compositions comprises a novel combination of vitamins A, E, C, and selenium, and a mixture of alfalfa, artichoke, cabbage, carrot, green leek, green barley, papaya, parsley, spinach, and strawberry juice concentrates .
- the second class of compositions of the present invention may be administered in two antioxidant lozenges.
- the preferred weight of each of the antioxidant lozenges is between about 1,000 mg to about 2000 mg, and preferably about 1,500 mg .
- the total weight of one dosage of the second class of compositions of the present invention is between about 2,000 mg and about 4,000 mg, and most preferably about 3,000 mg .
- the vitamin A, E, C, selenium, and juice concentrate components of the second class of nutritional supplements of the present invention are the same as those described for the first class of compositions, both in terms of amounts used in the antioxidant lozenges and with respect to the sources of those components. Since the second class of compositions of the present invention falls within the description of the antioxidant component of the first class of compositions, it is understood that the first and second classes of nutritional supplement compositions are different aspects of the same nutritional supplement invention disclosed herein. III . Preparation of the Nutritional Supplements of the Invention
- the active ingredients are blended in intimate admixture with a suitable carrier according to conventional compounding techniques.
- a suitable carrier may take a wide variety of forms depending upon the form of preparation desired for administration, e.g., oral, sublingual, nasal, or parenteral .
- any of the usual media may be employed.
- oral liquid preparations e.g., suspensions, elixirs, and solutions
- media containing for example, water, oils, alcohols, flavoring agents, preservatives, coloring agents and the like may be used.
- Carriers such as starches, sugars, diluents, granulating agents, lubricants, binders, disintegrating agents, and the like may be used to prepare oral solids (e.g., powders, capsules, pills, tablets, and lozenges) .
- Controlled release forms may also be used. Because of their ease in administration, tablets, pills, and capsules represent the most advantageous oral dosage unit form, in which case solid carriers are obviously employed. If desired, tablets may be sugar coated or enteric coated by standard techniques.
- non-essential ingredients may include in weight per lozenge: about 2 mg to about 10 mg biotin; about 1 mg to about 15 mg pantothenic acid; about 100 mg to about 300 mg calcium carbonate; about 0.01 mg to about 0.1 mg potassium iodide; about 5 to about 25 mg iron ortho phosphate; about 25 to about 100 mg magnesium oxide; about 1 to about 10 mg copper gluconate; about 2 to about 10 mg zinc oxide; about 2 mg to about 15 mg manganese gluconate; about 5 mg to about 15 mg molybdenum yeast (where there is about 2 micrograms of molybdenum per gram of yeast or alternatively expressed as 2,000 ppm) [Redstar] ; about 2 mg to about 20 mg chromium yeast (about 2,000 ppm) [Redstar]; about 5 to about 50 mg selenium yeast (about
- EXAMPLE 1 The following components are co-administered to comprise a single dosage of the first class of compositions of the present invention.
- Antioxidant component (2 lozenges)
- Vitamin A 1 000 IU
- Vitamin B-12 2.15 mg
- Barley juice concentrate (approx. 20-1) 80 mg
- Spinach juice concentrate (approx. 20-1) 50 mg
- Alfalfa juice concentrate (approx. 20-1) 50 mg
- Carrot juice concentrate (approx. 20-1) 40 mg Cabbage juice concentrate (approx. 20-1) 60 mg Strawberry juice concentrate (approx. 20-1) 60 mg
- Papaya juice concentrate (approx. 20-1) 60 mg
- Apple juice concentrate (approx. 20-1) 60 mg
- Ginkgo biloba component (1 lozenge)
- Ginkgo biloba extract (Westar Nutrition) 60 mg
- the following components are co-administered to comprise a single dosage of the first class of compositions of the present invention.
- Barley juice concentrate (approx. 20-1) 20 mg Spinach juice concentrate (approx. 20-1) 50 mg Alfalfa juice concentrate (approx. 20-1) 50 mg Parsley juice concentrate (approx. 20-1) 70 mg
- Multi-vitamin component (2 lozenges)
- Vitamin B-12 2.15 mg
- Barley juice concentrate (approx. 20-1) 80 mg
- Spinach juice concentrate (approx. 20-1) 50 mg
- Alfalfa juice concentrate (approx. 20-1) 50 mg
- Parsley juice concentrate (approx. 20-1) 50 mg
- Carrot juice concentrate (approx. 20-1) 40 mg Cabbage juice concentrate (approx. 20-1) 60 mg Strawberry juice concentrate (approx. 20-1) 60 mg
- Papaya juice concentrate (approx. 20-1) 60 mg
- Apple juice concentrate (approx. 20-1) 60 mg
- Ginkgo biloba component (1 lozenge) Ginkgo biloba extract (Westar Nutrition) 60 mg Brown rice powder (carrier) 440 mg
- composition falls within the first class of compositions of the present invention, and is in the form of a single lozenge for administration.
- Vitamin B-12 15 mg
- Barley juice concentrate (approx. 20-1) 580 mg
- Carrot juice concentrate (approx. 20-1) 40 mg
- Apple juice concentrate (approx. 20-1) 60 mg
- EXAMPLE 4 The following composition falls within the first class of compositions of the present invention, and is in the form of a single lozenge for administration.
- Barley juice concentrate (approx. 20-1) 50 mg Spinach juice concentrate (approx. 20-1 ) 5 mg Alfalfa juice concentrate (approx. 20-1 ) 5 mg Parsley juice concentrate (approx. 20-1 ) 5 mg Artichoke juice concentrate (approx. 20 -1) 2 mg
- Carrot juice concentrate (approx. 20-1) 1.5 mg Cabbage juice concentrate (approx. 20-1 ) 10 mg Strawberry juice concentrate (approx. 20-1) 2 mg Papaya juice concentrate (approx. 20-1) 2 mg Apple juice concentrate (approx. 20-1) 2 mg
- Kiwi juice concentrate (approx. 20-1) 2 mg Acorn Squash juice concentrate (approx. 20-1)2 mg Grapefruit juice concentrate (approx. 20-1) 2 mg Celery juice concentrate (approx. 20-1) 2 mg Orange juice concentrate (approx. 20-1) 2 mg
- Kale juice concentrate (approx. 20-1) 2 mg Tomato juice concentrate (approx. 20-1) 2 mg Lettuce juice concentrate (approx. 20-1 ) 2 mg Banana juice concentrate (approx. 20-1) 2 mg Ginkgo biloba extract 14 mg Maltodextrin 150 mg EXAMPLE 5
- the objectives of the study were to determine (1) whether oral intake of the composition results in increased levels of calcium ion in the human blood; (2) whether oral intake of the composition influences the levels of HDL in the lipid fraction distribution; and (3) whether oral intake of the composition influences the blood glucose levels.
- a total of 50 subjects with ages between 45 and 65 years with abnormal lipid profiles were divided into 2 groups.
- One group (25 subjects) received placebo packages and ingested this twice a day, once in the morning and once in the evening.
- the other group (25 subjects) received a composition of the present invention which included two multi -vitamin lozenges, 1 antioxidant lozenge, 1 ginkgo biloba gelatin capsule, and 1 green barley lozenge, and ingested twice daily, once in the morning and once in the afternoon.
- the below-described results were compiled after a 2 month testing period.
- the identity of the lozenges was unknown by the subjects, and to the examiner (i.e., a double blind study) .
- Blood serum (approximately 4 cc) was collected at the starting time and again after the completion of two months of usage.
- a fasting lipid profile was conducted on the plasma samples using a lipid fractionation panel automated system [Hewlett-Packard Co.].
- measurements of electrolytes (including calcium ion) and glucose levels were made using the Chem 18 automated system [Hewlett-Packard Co . ] .
- EXAMPLE 6 The following composition falls within the second class of compositions of the present invention, and is in the form of a single lozenge for administration.
- Vitamin A (from beta carotene) 5,000 IU
- Vitamin C 500 mg Vitamin E 100 IU
- Barley juice concentrate (approx. 20-1) 240 mg
- Carrot juice concentrate (approx. 20-1) 260 mg
- EXAMPLE 7 The following composition falls within the second class of compositions of the present invention, and is in the form of a single lozenge for administration. Ingredient Approximate
- Vitamin A (from beta carotene) 1 100,,01 30000 IU
- Barley juice concentrate (approx. 20-1) 260 mg Spinach juice concentrate (approx. 20-1] 280 mg Alfalfa juice concentrate (approx. 20-1] 260 mg Parsley juice concentrate (approx. 20-1] 260 mg Artichoke juice concentrate (approx. 20-1 1]) 240 mg Carrot juice concentrate (approx. 20-1) 260 mg Cabbage juice concentrate (approx. 20-1) 250 mg Strawberry juice concentrate (approx. 20- -1) 250 mg Papaya juice concentrate (approx. 20-1) 260 mg
- composition falls within the second class of compositions of the present invention, and is in the form of a single lozenge for administration.
- Vitamin A (from beta carotene) 1100,, i0 00000 IU
- Vitamin C 500 mg Vitamin E 250 IU
- Barley juice concentrate (approx. 20-1) 280 mg
- Carrot juice concentrate (approx. 20-1) 260 mg
- Vitamin A (from beta carotene) 20,000 IU
- Vitamin C 1 000 mg
- Barley juice concentrate (approx. 20-1) 235 mg
- Alfalfa juice concentrate (approx. 20-1) 250 mg
- Carrot juice concentrate (approx. 20-1) 260 mg
- Papaya juice concentrate (approx. 20-1) 260 mg
- Each subject had blood drawn at three specific times: before the study commenced (as a baseline) ; at the end of the first arm of the study; and at the end of the second arm of the study. Blood samples were drawn at three different times of day during each period: 8:00 am (fasting levels, prior to the first dose); 12:00 pm (prior to lunch); and 4:00 pm (prior to dinner and to the second dose) .
- the antioxidant tablets used were of the following composition : Ingredient Approximate
- Vitamin A (from beta carotene) 2,500 IU
- Barley juice concentrate (approx. 20-1) 120 mg
- Alfalfa juice concentrate (approx. 20-1) 145 mg
- Carrot juice concentrate (approx. 20-1) 130 mg
- Papaya juice concentrate (approx. 20-1) 130 mg
- Placebo tablets contained mineral oil. Each of these tablet were ingested twice daily as per the schedule described above.
- Data are expressed as averages of groups compared to placebo with each individual acting as their own placebo (since each subject underwent both a test arm and placebo arm of the study) . Significance was determined using paired Student's t-test for all data except beta-carotene where unpaired Student's t-test was employed. For beta-carotene, data was collected from 5 subjects only in each arm of the study. The results demonstrated that at fasting levels, 80 percent of the subjects demonstrated a 10 percent reduction of total plasma oxidants at a 99 percent confidence level over placebo during intake of antioxidant vitamins. Measurements for oxidants obtained later during the day showed that only 50 and 60 percent of the subjects demonstrated a decrease for the noon and 4:00 pm samples respectively, presumably because of interference of food substances absorbed and released into the plasma .
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to nutritional supplements to the human diet used to increase levels of high density lipoprotein (HDL) and calcium ions, and decrease levels of free radicals and glucose in human blood plasma. More specifically, the present invention teaches novel nutritional supplements which comprise a first class of compositions that contain a novel combination of: (1) a specific antioxidant composition; (2) a specific green barley composition; (3) a specific vitamin and mineral composition, and (4) a particular tincture of ginkgo biloba extract, as well as methods of preparing the nutritional supplements. In addition, the present invention comprises a second class of compositions that contain a novel combination of vitamins A, E, C, selenium, and specific juice concentrates, as well as methods of preparing these nutritional supplements.
Description
NUTRITIONAL SUPPLEMENT COMPOSITION AND USE
BACKGROUND OF THE INVENTION
1 • Field of the Invention
The present invention relates to nutritional supplements to the human diet, and more specifically to nutritional supplements which contain a combination of naturally occurring substances such as vitamins and minerals, antioxidants , green barley extract, and ginkgo biloba extract.
2. Background Diets complete in nutritional substance are important for the human body in order to afford consistent high levels of optimum performance, both in cognitive ability and physical health. Although the exact needs of the human species to develop and maintain peak performance on a daily basis and sustain such for the duration of the human life are not completely understood, it is widely recognized that maintaining balanced nutrition coupled with sensible levels of daily exercise are the fundamental bases for optimizing the condition of the human body. It is also widely accepted that the risk of many common ailments from environmental sources or many ailments arising from genetic consequences can be reduced through the daily practice of, in addition to exercise, a complete nutritional regime fortified with certain vitamins, minerals, food and herb concentrates, especially, in the case of certain genetic consequences, during the antenatal period. Increased human longevity is understood to be a potential consequence of these daily practices.
uarαiovascuiar αisease resulting from the buildup of arterial plaque is a leading cause of illness or death. Arterial plaque is precipitous material formed chiefly of oxidized low density lipoprotein (0-LDL) . The buildup of plaque in the form of O-LDL in the arteries is understood to be a factor in ischaemic heart disease. Free radical oxidants, many of which come from naturally occurring sources such as sun exposure, metabolism of certain nutrients, and exercise, act to oxidize low density lipoprotein (LDL) into its deleterious form, 0-LDL. Hence, free radical "scavengers" such as vitamins A, E, C, and selenium are believed to react with these oxidants so that they are not available to form O- LDL, thus lowering the risk of arterial plaque deposits in blood vessels. In contrast, the presence of high density lipoprotein (HDL) in the body is understood to have beneficial health effects. Specifically, HDL is known to be a more soluble form of lipoprotein; hence its presence does not significantly contribute to the formation of arterial plaque. In addition, it is known that HDL is able to absorb plaque material and may thus directly reduce the amount of arterial plaque .
3. Description of the Background Art
Certain vitamins and minerals, antioxidants , and plant extracts are generally known to have beneficial health effects. For example, several beneficial aspects of antioxidants have been known for many years. Antioxidants are chemicals that react with free radicals, such as hydroxy
radical, to protect certain biological systems. The removal of free radicals from the body has been suggested to increase human longevity -- specifically, the presence of antioxidants including superoxide dismutase (SOD) , carotenoids, alpha- tocopherol, and uric acid is suggested to have a positive correlation with resistance to spontaneous autoxidation of tissues and oxidative damage to DNA in mammals [Cutler, R., Am. J. Clin. Nutr. , 5J3.373S-9S (1991)]. Antioxidants are also known to limit destruction of healing brain tissue by free radicals as shown by the method for resuscitating the brain using vitamins such as A, E and C or selenium [See, Klatz et al . , U.S. Patent No. 5,149,321 and PCT application PCT/US92/06681] .
In addition to their antioxidant activity, vitamins A, C, and E are well known to have other beneficial health effects. For example, vitamin E is known to help maintain proper blood sugar levels. As another example, vitamin C is known to play an integral role in the integrity of connective and structural tissues in the body. Vitamin A is known to play a role in maintaining good vision as well as in growth and development. Hence, an adequate supply of these vitamins is essential in maintaining optimum health. The use of vitamins A, E, C and selenium has been proposed as a means to inhibit or prevent collagen cross-linking in human skin when used in combination with certain active peptides [See, Geoffrey et al . , PCT application WO 90/06102] .
Green barley is known to be a rich source of highly metabolizable vitamins and minerals such as vitamins A, Bl ,
B2 , B6, and C, potassium, magnesium, and zinc. In addition, green barley also has a high concentration of the enzyme superoxide dismutase (SOD) , which has been shown to have high levels of antioxidant activity. Green barley is believed to be an important nutrient in the regulation of the digestive process because the micronutrients, enzymes (e.g., SOD), and fiber contained in green barley are believed to improve intestinal function [D. Walsh et al . , British J. Nutr .. 70:621-630 (1993) ] . Ginkgo biloba has been a staple Chinese herbal ingredient for thousands of years, and is frequently recommended by Chinese herbal practitioners for coughs, asthma and acute allergic inflammations. There are many active organic compounds in ginkgo biloba, including Ginkgolide B which has been shown to be an active constituent and which apparently works by interfering with platelet activating factor (PAF) . PAF is known to have several biological functions, including induction of platelet aggregation, neutrophil degranulation and oxygen radical production, and increasing microvascular permeability and bronchoconstriction. It has been shown that by its inhibitory interaction with PAF, Ginkgolide B helps improve cerebral metabolism and protect the brain against hypoxic damage in laboratory animals with cerebral ischaemia [Kleijnen, J. and Knipschild, P., The Lancet, 340 : 1136-39 (1992)] . In addition, ginkgo biloba extract is licensed in Germany for the treatment of cerebral dysfunction, hearing loss resulting from cervical syndrome, and peripheral arterial circulatory disturbances with intact circulatory reserve
(intermittent claudication) [See, Kleijnen, J. and Knipschild, P., cited above] . Other studies indicate the efficacy of using ginkgo biloba extract to improve mental acuity [See, e.g., Nutrition Today, July/August : 11-18 (1988); Ginkgo Biloba Extract in Perspective, Auckland, New Zealand: ADIS Press Limited: Iff (1990) ] .
A healthy balance of vitamins and minerals has been known to be critical to sustain a healthy human body. Many combinations of vitamins and minerals have been taught over the years as food supplements beneficial to a human health, and the daily ingestion of fruits and vegetables has long been recognized as critical to a healthy diet .
There remains a need in the art for novel daily food supplements that provide high levels of antioxidant activity, and thereby increase cardiovascular fortitude, maintain proper blood sugar balance, support mental awareness and intellectual performance, reduce the risk of digestive problems, and strengthen connective and structural tissues.
SUMMARY OF THE INVENTION The compositions of the present invention are novel combinations of selected ingredients that are known to benefit the human organism. More particularly, a first class of nutritional supplements of the present invention provides a novel combination of: (1) a specific antioxidant component; (2) a specific green barley component; (3) a specific vitamin and mineral component, and (4) a particular tincture of ginkgo biloba extract, the combination of which provides for improved
nutrition when ingested by humans. A second class of nutritional supplements of the present invention provides a novel combination of ingredients of the antioxidant component, the combination of which provides for improved nutrition when ingested by humans .
It is therefore an object of the invention to provide a first class of novel compositions containing a combination of: (1) a specific antioxidant component; (2) a specific green barley component; (3) a specific vitamin and mineral component, and (4) a particular tincture of ginkgo biloba extract. It is another object to provide a second class of nutritional supplement compositions containing a novel combination of ingredients of the antioxidant component. The present invention also teaches the use of these compositions to supplement the human diet. Therefore, it is an object of the invention to provide novel a method of supplementing the human diet using the dietary supplements taught herein.
It is a further object of the present invention to provide a method of preparing the nutritional supplements of the present invention.
It is yet another object of the present invention to provide nutritional supplements to safely reduce the risk of health problems arising from the presence of free radicals and other oxidants in human blood and tissues.
In still another object, the present invention provides for methods to maintain proper glucose levels in blood serum using the novel nutritional supplements of the invention.
Another object of the present invention is to increase levels of minerals such as calcium in human blood serum and tissues using the novel nutritional supplements of the present invention. Another object of the present invention is to increase levels of vitamins such as vitamins A and E and other nutrients such as beta-carotene in human blood serum and tissues using the novel nutritional supplements of the present invention . In a further object, the present invention provides methods for reducing the risk of the harmful biological effects of free radicals and other oxidants in the human system.
In still a further object, the present invention provides novel nutritional supplements used to effect memory enhancement .
DETAILED DESCRIPTION OF THE INVENTION
The novel nutritional compositions of the present invention significantly improve the general metabolic, circulatory and nervous systems of the human body, and thus help overcome, or diminish the effect of many of the metabolic problems that occur with the aging of the human system. The present compositions are novel combinations of naturally occurring substances, are non-toxic when administered according to the methods of the present invention, and provide for a more complete nutritional regime.
The present invention focuses on the development and maintenance of vitality and fortitude of the human body as a direct result of the daily oral intake of the compositions of the present invention. The aim of the present invention is to provide compositions that act on the human systems to safely reduce the risks of health problems arising from the presence of oxidants in the human blood and tissues, from low glucose levels in blood serum, and from inadequately low levels of minerals such as calcium in the human blood serum and tissues Helping avoid the harmful biological effects of free radicals m the human system, namely inflammation, collagen degradation, and cardiovascular disease, among others, is a prime objective of the present invention. The present invention also provides a composition and method that may maintain proper blood sugar levels and effect memory enhancement .
Some of the observable metabolic changes effected as a direct result of administering the compositions of the present invention are significant, and include: (a) a significant lowering of the blood sugar level; (b) an increase in the concentration of high density lipid protein (HDL) in the blood serum; (c) an increase m blood serum calcium levels, and (d) an increase in blood serum levels of nutrients known to improve human health such as vitamins A and E, and beta- carotene.
Evidence of the effect of the compositions of the invention on calcium ion concentrations and blood glucose levels may be seen in the Examples below. For humans, a
normal blood glucose level is approximately 100 g/dl . It is generally understood that persons having a blood glucose level of between 100 mg/dl and 150 mg/dl have above-normal levels, and individuals having a blood glucose level of greater than 150 mg/dl are considered diabetic. Since the compositions of the present invention are able to cause an approximate 22% decrease in the level of blood glucose, individuals who have above normal levels of blood glucose may have their levels reduced to normal levels upon administration of the compositions of the present invention.
The compositions of the present invention are also believed to have an effect on memory enhancement because they contain ginkgo, a substance known to have an effect on persons suffering from difficulties of concentration and memory, absent mindedness, confusion, and headaches [See, Kleijnen, J. and Knipschild, P., cited above].
The compositions of the present invention represent a combination of nutritive food supplements that work together with various metabolic systems of the human body. Each composition in a first class of novel nutritional supplement compositions contains at least one of each of the following four components: (1) a compendial grade multi -vitamin and mineral dietary supplement, where a primary source of the vitamins is from specific combinations of food concentrates; (2) a green barley extract; (3) a compendial grade of a specified combination of antioxidant vitamins A, C, E, and selenium, where the primary source of the antioxidants arises from selected food concentrates which may or may not be the
same as the selected food concentrates of the multi -vitamin and mineral component; and (4) a ginkgo biloba extract. Each of these four components is processed separately, in a pharmaceutically acceptable manner, either as solid powder, tablets, lozenges, pills, capsules, or in liquid forms, and may be administered separately or in suitable combinations with other components, including, for example, being combined into a single preparation for administration. More specifically, the first class of compositions of the present invention can be administered as: (1) a dosage comprising multiple lozenges of separate and distinct components (e.g., a green barley extract component, an antioxidant component, a multi-vitamin and mineral component, and a ginkgo biloba extract component), or, more preferably; (2) a dosage comprising multiple lozenges, each of the same composition, where the four components are combined into a single lozenge; or (3) other dosage forms known in the art. Each of the vitamins and minerals as well as the ginkgo biloba and green barley extracts of the components are commercially available, and can be blended to form a single composition or can form multiple compositions which may be co-administered.
A summary of the ingredients of the food concentrates and their respective antioxidant element (s) is provided in Table I. TABLE I
Component Vitamins and Minerals Antioxidant Element
Acorn Squash Potassium, Calcium, Vitamin C Phosphorus, Vitamin Bl, B2, C
Alfalfa Vitamins A, Bl, B2 , B6 , Vitamins A, C, E C, E, K, Niacinamide, Pantothenic acid, Folic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous , Zinc
Apple Potassium, Manganese, Vitamins A, C Cobalt, Molybdenum, Phosphorus, Vanadium, Vitamins A, Bl, B2 , C, Folic acid
Artichoke Vitamins A, Bl, B2 , B6, Vitamins A, C C, Niacinamide, Pantothenic acid, Folic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc
Avocado Vitamin A, Calcium, Vitamin A Phosphorus , Iron , Potassium, Sodium, Thiamine, Riboflavin, Niacin, Ascorbic acid
Bananas Vitamin A, Calcium, Vitamin A Phosphorus, Iron, Potassium, Sodium, Thiamine, Riboflavin, Niacin, Ascorbic acid
Broccoli Potassium, Magnesium, Vitamins A, C, E Calcium, Phosphorus, Vitamins A, E, C, Bl
Brussels Potassium, Magnesium, Vitamins A, E, C, Sprouts Calcium, Copper, Selenium Phosphorus, Selenium, Vitamins A, E, C, B2, Folic acid
Cabbage Vitamins A, Bl, B2 , C, Vitamins A, C Niacinamide, Folic acid, Calcium, Iron, Magnesium, Potassium, Phosphorous
Cantaloupe Vitamin A, Calcium, Vitamin A Phosphorus, Iron, Potassium, Sodium, Thiamine, Riboflavin, Niacin, Ascorbic acid
Carrot Vitamins A, Bl , B2 , B6 , Vitamins A, C C, Niacinamide, Pantothenic acid, Folic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc
Cauliflower Potassium, Magnesium, Vitamins A, C, E Calcium, Phosphorus, Vitamins A, E, K, C, Folic acid
Celery Potassium, Iron, Vitamins A, C, E Calcium, Phosphorus, Vitamins A, E, K, C, Folic acid
Collard Greens Potassium, Magnesium, Vitamins A, C Calcium, Vitamins A, C
Grapefruit Vitamins A and C, Vitamins A, C Calcium, Phosphorus, Iron, Potassium, Sodium, Thiamine, Riboflavin, Niacin, Ascorbic acid
Green Leek Potassium, Calcium, Vitamins E, C Copper, Phosphorus, Vitamins E, B2, C
Green Barley Vitamins A, Bl, B2 , B6 , Vitamins A, C, SOD C, K, Niacinamide, Pantothenic acid, Folic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc, Superoxide Dismutase (SOD)
Kale Potassium, Magnesium, Vitamins A, C, E, Calcium, Chromium, Selenium Selenium, Vitamins A, E, C
Kiwi Fruit Potassium, Magnesium, Vitamins A, C Calcium, Phosphorus, Vitamins A, C, Bl, B2
Lettuce Potassium, Magnesium, Vitamins A, C, E Calcium, Vitamins A, E, C, Bl, B2, Folic acid
Onion Potassium, Magnesium, Vitamins A, C, Calcium, Copper, Cobalt, Selenium Chromium, Vanadium, Phosphorus, Selenium, Vitamins A, Bl, B2 , C, Biotin, Folic acid
Papaya Vitamins A, Bl, B2 , B6, Vitamins A, C C, Niacinamide, Pantothenic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc
Parsley Vitamins A, Bl, B2 , B6, Vitamins, A, C C, Niacinamide, Pantothenic acid, Folic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc, Para ammobenzoic acid (PABA)
Potato Potassium, Vitamins A, Vitamins A, C, and B2, C, K, E, Folic acid, E Phosphorus, Iodide, Calcium, Chromium
Prune Vitamin A, Calcium, Vitamin A Phosphorus, Iron, Potassium, Sodium, Thiamine, Riboflavin, Niacin, Ascorbic acid
Spinach Vitamins A, Bl, B2 , B6 , Vitamins A, C, E C, E, Niacinamide, Pantothenic acid, Folic acid. Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc
Strawberry Vitamins A, Bl, B2 , B6, Vitamins A, C C, Niacinamide, Pantothenic acid, Folic acid, Calcium, Copper, Iron, Magnesium, Manganese, Potassium, Phosphorous, Zinc
Sweet Potato Potassium, Vitamins Bl, Vitamin C, Selenium B2, C, Folic acid, Phosphorus, Selenium, Calcium
Swiss Chard Potassium, Magnesium, Vitamins A, C Calcium, Vitamins A, C
Tomato Potassium, Magnesium, Vitamins A, c, Calcium, Nickel, Selenium Chromium, Phosphorus, Boron, Selenium, Vitamins A, C, K, Bl, B2, Folic acid
I . First Class of Nutritional Supplements A. Antioxidant Component As a preferred embodiment, a dosage of the antioxidant component of the first class of nutritional supplement compositions of the present invention may consist of two lozenges for human oral consumption. In such an embodiment, the preferred weight of each of the antioxidant lozenges is between about 1,000 mg to about 2000 mg, and preferably about 1,500 mg. The total weight of one dosage of the antioxidant component of the present invention is between about 2,000 mg and about 4,000 mg, and most preferably about 3,000 mg . The antioxidant lozenge comprises vitamins A, E, C, and selenium, and at least one juice concentrate, selected from the plurality of juice concentrates including acorn squash, alfalfa, apple, artichoke, avocado, bananas, broccoli, brussels sprouts, cabbage, cantaloupe, carrot, cauliflower, celery, collard greens, grapefruit, green leek, green barley, kale, kiwi fruit, lettuce, onion, papaya, parsley, potato, prune, spinach, strawberry, sweet potato, swiss chard, and tomato juice concentrates.
The total weight of the combination of vitamin C, vitamin A, vitamin E, and selenium in the antioxidant component of the present invention is about 10% to about 50% of the total
weight of the antioxidant lozenge, preferably about 15% to about 30% of the total weight of the antioxidant lozenge and most preferably about 20% of the total weight of the antioxidant lozenge. A suitable antioxidant component consistent with the present invention comprises about 5,000 IU to about 20,000 IU of vitamin A, more preferably about 7,500 IU to about 15,000 IU and most preferably about 9,000 IU to about 10,000 IU of vitamin A (in the form of beta-carotene) per dose. A compendial grade of vitamin C can be employed in the antioxidant component of the present composition. The antioxidant component comprises, by weight percent, about 200 mg to about 2,000 mg of vitamin C, preferably about 300 mg to about 1,000 mg of vitamin C and most preferably about 450 mg to about 550 mg per dose.
A compendial grade of vitamin E can also be employed in the antioxidant component of the present composition. The antioxidant component comprises about 100 IU to about 500 IU of vitamin E, preferably about 175 IU to about 425 IU of vitamin E, and most preferably about 190 IU to about 225 IU of vitamin E per dose.
A compendial grade of selenium can be incorporated in the antioxidant component of the present invention. The antioxidant component of the present invention comprises, by weight, about 50 micrograms to about 200 micrograms of selenium, preferably about 75 micrograms to about 150 micrograms, and most preferably about 100 micrograms of selenium per dose .
The total weight of the juice concentrates in the preferred embodiment of the antioxidant component of the present invention is about 30 to about 80% of the total weight of the antioxidant lozenge, and most preferably about 60% of the weight of the antioxidant lozenge.
A suitable composition consistent with the present invention comprises juice concentrates having a concentration of at least 10 times that of the native juice in the unconcentrated form, and preferably about 15 times more concentrated, and most preferably about 20 times more concentrated than the unconcentrated juice. In concentrated form, the juice concentrates are essentially anhydrous, and are generally in powder form.
When present, a form of acorn squash suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention. When present, a form of alfalfa juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about
15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
When present, a form of apple juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about
15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
When present, a form of artichoke juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention. When present, a form of avocado juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention.
When present, a form of banana juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention.
When present, a form of broccoli juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention .
When present, a form of brussels sprout juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention .
When present, a form of cabbage juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 1% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
When present, a form of cantaloupe juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5%
to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
When present, a form of carrot juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention. When present, a form of cauliflower juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
When present, a form of celery juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention. When present, a form of collard greens juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about
1% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention. When present, a form of grapefruit juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
When present, a form of green leek juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
When present, a form of green barley juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention.
When present, a form of kale juice suitable for use to supplement the human diet that can be used in the antioxidant
component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention.
When present, a form of kiwi fruit juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention.
When present, a form of lettuce juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 1% of the weight of the juice concentrate composition of the present invention. When present, a form of onion juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 5% of the weight of the juice concentrate composition of the present invention.
When present, a form of papaya juice suitable for use to supplement the human diet that can be used in the antioxidant
component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention. When present, a form of parsley juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about
15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention. When present, a form of potato juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention. When present, a form of prune juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention. When present, a form of spinach juice suitable for use to supplement the human diet that can be used in the antioxidant
component of the present invention comprises about 5% to about 25% of the weight of the total juice concentrate compound of the present invention, more preferably about 7.5% to about 15%, and most preferably about 8% to about 12% of the weight of the juice concentrate composition of the present invention. When present, a form of strawberry juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 7.5% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
When present, a form of sweet potato juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 10% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention. When present, a form of swiss chard juice suitable for use to supplement the human diet that can be used in the antioxidant component of the present invention comprises about 0.5% to about 7.5% of the weight of the total juice concentrate compound of the present invention, and most preferably about 2% of the weight of the juice concentrate composition of the present invention.
When present, a form of tomato juice suitable for use to supplement the human diet that can be used in the antioxidant
component of the present invention comprises about 1% to about 10% of the weight of the total uice concentrate compound of the present invention, and most preferably about 3% of the weight of the juice concentrate composition of the present invention.
B . Multi-Vitamin and Mineral Component
In a preferred embodiment, the multi -vitamin and mineral component of the first class of compositions of the present invention consists of two multi -vitamin and mineral lozenges for human oral consumption taken twice daily (total of four lozenges per day -- i.e., two doses per day) . The preferred weight of each of the lozenges is between about 750 mg to about 1,500 mg, preferably about 1,000 mg . The total weight of one dosage of the vitamm-mmeral component of the present invention is between about 1,500 mg and about 3,000 mg and most preferably about 2,000 mg .
The multi-vitamin and mineral component of the first class of compositions of the invention may be comprised of juice concentrates -- the total weight of which is about 4% to about 25% the total weight of the multi-vitamin and mineral lozenge, and most preferably about 12% of the weight of the multi-vitamin and mineral lozenge. When the first class of nutritional supplement is administered as a single lozenge, the total weight of the juice concentrate is about 3% to about 50%, and most preferably about 5% to about 35% of the total weight of the lozenge.
The total weight of the combination of non-juice concentrate-derived vitamins and minerals in the multi -vitamin component of the first class of compositions of the present invention is about 10% to about 90% of the total weight of the multi-vitamin and mineral lozenge, preferably about 15% to about 80% of the total weight of the multi -vitamin and mineral lozenge and most preferably about 65% of the total weight of the multi -vitamin and mineral lozenge.
In a preferred embodiment, a suitable multi-vitamin and mineral component of the first class of compositions of the present invention comprises about 1,000 IU to about 10,000 IU of vitamin A, more preferably about 1,500 IU to about 4,500 IU and most preferably about 3,500 IU of vitamin A (in the form of beta-carotene) per lozenge. Vitamin A may be contributed by the juice concentrates as described above, or it may be contributed in non-juice form.
In a preferred embodiment, a compendial grade of vitamin C can be employed in the multi -vitamin composition. Each lozenge of the multi-vitamin component of the first class of compositions of the present invention comprises, by weight, about 10 mg to about 200 mg of vitamin C, preferably about 15 mg to about 175 mg of vitamin C and most preferably about 125 mg per lozenge. Vitamin C may be contributed by the juice concentrates as described above, or it may be contributed in non-juice form.
In a preferred embodiment, a suitable multi -vitamin component of the first class of compositions of the present invention comprises about 10 IU to about 1,000 IU of
vitamin D, more preferably about 15 IU to about 350 IU and most preferably about 100 IU of vitamin D per lozenge.
A suitable multi-vitamin component of the first class of compositions of the present invention comprises about 5 IU to about 50 IU of vitamin E, more preferably about 5 IU to about 35 IU and most preferably about 11.5 IU of vitamin E per lozenge. Vitamin E may be contributed by the juice concentrates as described above, or it may be contributed in non-juice form. In a preferred embodiment, a compendial grade of folic acid or folic acid salt may be employed in the multi -vitamin component. Each lozenge of the multi-vitamin component of the present invention comprises, by weight, about 0.03 mg to about 1 mg of folic acid, preferably about 0.04 mg to about 0.06 mg of folic acid, and most preferably about 0.05 mg of folic acid per lozenge .
In a preferred embodiment, a compendial grade of thiamine (B-l) may be employed in the multi-vitamin component. Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 0.01 mg to about 1.0 mg of thiamine (B-l), preferably about 0.15 mg to about 0.75 mg of thiamine (B-l) and most preferably about 0.5 mg of thiamine (B-l) per lozenge.
In a preferred embodiment, a compendial grade of riboflavin may be employed in the multi-vitamin composition. Each lozenge of the multi-vitamin composition of the present invention comprises, by weight, about 0.01 mg to about 5.0 mg of riboflavin, preferably about 0.15 mg to about 2.75 mg of
riboflavin and most preferably about 0.5 mg of riboflavin per lozenge .
In a preferred embodiment, a compendial grade of niacin may be employed in the multi -vitamin component. Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 1.0 mg to about 100 mg of niacin, preferably about 0.5 mg to about 10 mg of niacin and most preferably about 7.5 mg of niacin per lozenge.
In a preferred embodiment, a compendial grade of vitamin B-6 may be employed in the multi -vitamin component. Each lozenge of the multi-vitamin component of the present invention comprises, by weight, about 1.0 mg to about 10.0 mg of vitamin B-6, preferably about 1.5 mg to about 7.5 mg of vitamin B-6 and most preferably about 1.125 mg of vitamin B-6. In a preferred embodiment, a compendial grade of vitamin B-12 may be employed in the multi-vitamin component. Each lozenge of the multi-vitamin component of the present invention comprises, by weight, about 1.0 mg to about 10.0 mg of vitamin B-12, preferably about 1.5 mg to about 7.5 mg of vitamin B-12 and most preferably about 2.25 mg of vitamin B- 12.
In a preferred embodiment, a compendial grade of biotin may be employed in the multi-vitamin component. Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 0.10 mg to about 1.00 mg of biotin, preferably about 0.15 mg to about 0.95 mg of biotin and most preferably about 0.75 mg of biotin.
In a preferred embodiment, a compendial grade of zinc may be employed the multi -vitamin component. Each lozenge of the multi-vitamin component of the present invention comprises, by weight, about 1.0 mg to about 10.0 mg of zinc, preferably about 1.5 mg to about 7.5 mg of zinc and most preferably about 5.0 mg of zinc.
In a preferred embodiment, a compendial grade of manganese may be employed in the multi-vitamin component. Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 1.0 mg to about 10.0 mg of manganese, preferably about 1.15 mg to about 1.75 mg of manganese and most preferably about 1.25 mg of manganese.
In a preferred embodiment, a compendial grade of selenium may be employed in the multi-vitamin component. Each lozenge of the multi -vitamin component of the present invention comprises, by weight, about 5 micrograms to about 20 micrograms of selenium, preferably about 7.5 micrograms of selenium.
In a preferred embodiment, a suitable multi -vitamin and mineral component of the first class of compositions of the present invention optionally comprises juice concentrates having a concentration of at least 10 times that of the native juice in the unconcentrated form, and preferably about 15 times more concentrated, and most preferably about 20 times more concentrated than the unconcentrated juice. In concentrated form, the juice concentrates are essentially anhydrous, are generally in powder form, and may be selected from the juice concentrates of the antioxidant component.
C. Green Barley Component
In a preferred embodiment, the green barley component of the first class of compositions of the present invention comprises, by weight percent, about 60% to about 90%, and most preferably about 80% green barley juice concentrate [Westar
Nutrition, Inc.] . A preferred green barley preparation of the present invention consists of one lozenge (one dose) twice per day for human consumption. A preferred weight of the green barley lozenge is from about 600 mg to about 1,000 mg and most preferably about 750 mg . This green barley component of the first class of compositions of the compositions of the present invention is a separate required component from the green barley juice concentrate that may exist as part of the antioxidant preparation. This green barley component, although separate and required, may take the same form as that described in the antioxidant section above.
D. Ginkgo Biloba Component
The ginkgo biloba extract component of the first class of compositions of the present invention consists of about 5% to about 35% and most preferably from about 10% to about 15% ginkgo biloba extract [Westar Nutrition, Inc.] . A preferred dosage of the ginkgo biloba extract component of the present invention consists of one lozenge twice a day for human consumption. A preferred weight of the lozenge is from about 400 mg to about 750 mg, and most preferably 500 mg .
E. Dosage of the First Class of Nutritional Supplements
A preferred dosage of the first class of compositions of the present invention may consist of six lozenges for human oral consumption -- two antioxidant lozenges, two vitamin and mineral lozenges, and one of each of the ginkgo biloba extract and green barley extract lozenges. The preferred weight of each of the antioxidant and vitamin and mineral lozenges is between about 1,000 mg to about 2,000 mg, preferably about 1,500 mg. The preferred weight of the green barley lozenge is about 600 mg to about 1,000 mg, and preferably about 750 mg . The preferred weight of the ginkgo biloba lozenge is about 400 mg to about 750 mg, and most preferably about 500 mg . The total weight of one dosage of the first class of compositions of the present invention is between 6,000 mg and 12,000 mg and most preferably about 9,000 mg . Alternatively, the components of the first class of compositions of the present invention may be combined into fewer than six lozenges to give the appropriate amounts of each component. In a preferred embodiment, a dosage is administered twice daily.
II . Second Class of Nutritional Supplements In a second class of compositions of the present invention, select moieties of the antioxidant component of the first class of compositions of the present invention may provide for many of the beneficial health effects described above. Specifically, the second class of compositions may consist of two lozenges for human oral consumption. The second class of compositions of the present invention falls within the description of the antioxidant component of the
first class of compositions described above, but it is as specific combination of the ingredients of that component. More specifically, the second class of compositions comprises a novel combination of vitamins A, E, C, and selenium, and a mixture of alfalfa, artichoke, cabbage, carrot, green leek, green barley, papaya, parsley, spinach, and strawberry juice concentrates .
Similar to the first class of nutritional supplements described above, the second class of compositions of the present invention may be administered in two antioxidant lozenges. The preferred weight of each of the antioxidant lozenges is between about 1,000 mg to about 2000 mg, and preferably about 1,500 mg . The total weight of one dosage of the second class of compositions of the present invention is between about 2,000 mg and about 4,000 mg, and most preferably about 3,000 mg .
The vitamin A, E, C, selenium, and juice concentrate components of the second class of nutritional supplements of the present invention are the same as those described for the first class of compositions, both in terms of amounts used in the antioxidant lozenges and with respect to the sources of those components. Since the second class of compositions of the present invention falls within the description of the antioxidant component of the first class of compositions, it is understood that the first and second classes of nutritional supplement compositions are different aspects of the same nutritional supplement invention disclosed herein.
III . Preparation of the Nutritional Supplements of the Invention
To prepare the components of the invention from either class of compositions, the active ingredients are blended in intimate admixture with a suitable carrier according to conventional compounding techniques. Alternatively, each of the active ingredients for any or each of the four components may be combined in intimate admixture with a suitable carrier according to conventional compounding techniques. This carrier may take a wide variety of forms depending upon the form of preparation desired for administration, e.g., oral, sublingual, nasal, or parenteral .
In preparing the compositions in oral dosage form, any of the usual media may be employed. For oral liquid preparations (e.g., suspensions, elixirs, and solutions), media containing for example, water, oils, alcohols, flavoring agents, preservatives, coloring agents and the like may be used. Carriers such as starches, sugars, diluents, granulating agents, lubricants, binders, disintegrating agents, and the like may be used to prepare oral solids (e.g., powders, capsules, pills, tablets, and lozenges) . Controlled release forms may also be used. Because of their ease in administration, tablets, pills, and capsules represent the most advantageous oral dosage unit form, in which case solid carriers are obviously employed. If desired, tablets may be sugar coated or enteric coated by standard techniques.
In preparing the compositions of the invention, the above-described active ingredients may be combined with a
variety of non-essential ingredients which perform the functions described in the above description of dosage forms. Such non-essential ingredients may include in weight per lozenge: about 2 mg to about 10 mg biotin; about 1 mg to about 15 mg pantothenic acid; about 100 mg to about 300 mg calcium carbonate; about 0.01 mg to about 0.1 mg potassium iodide; about 5 to about 25 mg iron ortho phosphate; about 25 to about 100 mg magnesium oxide; about 1 to about 10 mg copper gluconate; about 2 to about 10 mg zinc oxide; about 2 mg to about 15 mg manganese gluconate; about 5 mg to about 15 mg molybdenum yeast (where there is about 2 micrograms of molybdenum per gram of yeast or alternatively expressed as 2,000 ppm) [Redstar] ; about 2 mg to about 20 mg chromium yeast (about 2,000 ppm) [Redstar]; about 5 to about 50 mg selenium yeast (about 1,200 ppm) [Redstar] ; about 2 mg to about 15 mg choline; and about 2 to about 15 mg inositol .
The following examples are illustrative only, and do not purport to limit the invention in any fashion.
EXAMPLE 1 The following components are co-administered to comprise a single dosage of the first class of compositions of the present invention. Antioxidant component (2 lozenges)
Ingredient Approximate Amount
Vitamin A 1, 000 IU
Vitamin C 500 mg
Vitamin E 250 IU
Selenium 70 μg Barley juice concentrate (20-1) 80 mg
Spinach juice concentrate (20-1) 50 mg
Alfalfa juice concentrate (20-1) 50 mg
Parsley juice concentrate (20-1) 50 mg
Artichoke juice concentrate (20-1) 70 mg
Carrot juice concentrate (20-1) 60 mg
Cabbage juice concentrate (20-1) 20 mg
Strawberry juice concentrate (20-1) 60 mg
Papaya juice concentrate (20-1) 40 mg
-Multi-vitamin component (2 lozenges)
Ingredient Approximate
Amount
Vitamin A 2,000 IU Vitamin C 25 mg
Vitamin E 15 iu
Selenium 5.3 μg
Folic acid 0.1 mg
Thiamine (B-l) 0.5 mg Riboflavin 0.5 mg
Niacin 7.5 mg
Vitamin B-6 1.5 mg
Vitamin B-12 2.15 mg
Biotin 0.115 mg Pantothenic acid 3.0 mg
Calcium 250 mg
Phosphorous 25 mg
Iodine 30 mg
Iron 5.1 mg Magnesium 50 mg
Copper 0.5 mg
Zinc 5 mg
Manganese 1.25 mg
Barley juice concentrate (approx. 20-1) 80 mg Spinach juice concentrate (approx. 20-1) 50 mg
Alfalfa juice concentrate (approx. 20-1) 50 mg
Parsley juice concentrate (approx. 20-1) 50 mg Artichoke juice concentrate (approx. 20-1) 70 mg
Carrot juice concentrate (approx. 20-1) 40 mg Cabbage juice concentrate (approx. 20-1) 60 mg Strawberry juice concentrate (approx. 20-1) 60 mg
Papaya juice concentrate (approx. 20-1) 60 mg
Apple juice concentrate (approx. 20-1) 60 mg
Ginkgo biloba component (1 lozenge) Ginkgo biloba extract (Westar Nutrition) 60 mg
Brown rice powder 440 mg
Green barley component (1 lozenge)
Green barley juice concentrate 600 mg
Malt dextrin 150 mg
EXAMPLE 2
The following components are co-administered to comprise a single dosage of the first class of compositions of the present invention.
Antioxidant component (2 lozenges)
Ingredient Approximate
Amount
Vitamin A 1,000 IU Vitamin C 500 mg Vitamin E 250 IU Selenium 100 μg
Barley juice concentrate (approx. 20-1) 20 mg Spinach juice concentrate (approx. 20-1) 50 mg Alfalfa juice concentrate (approx. 20-1) 50 mg Parsley juice concentrate (approx. 20-1) 70 mg
Artichoke juice concentrate (approx. 20- 1) 70 mg Carrot juice concentrate (approx. 20-1) 60 mg Cabbage juice concentrate (approx. 20-1) 20 mg Strawberry juice concentrate (approx. 20 --1) 60 mg Papaya juice concentrate (approx. 20-1] 40 mg
Multi-vitamin component (2 lozenges)
Ingredient Approximate
Amount
Vitamin A 2,000 IU Vitamin C 25 mg
Vitamin E 15 IU
Selenium 5.3 μg
Folic acid 0.1 mg
Thiamine (B-l) 0.5 mg Riboflavin 0.5 mg
Niacin 7.5 mg
Vitamin B-6 1.5 mg
Vitamin B-12 2.15 mg
Biotin 0.115 mg Pantothenic acid 3.0 mg
Calcium 250 mg
Phosphorous 25 mg
Iodine 30 mg
Iron 5.1 mg Magnesium 50 mg
Copper 0.5 mg
Zinc 5 mg
Manganese 1.25 mg
Barley juice concentrate (approx. 20-1) 80 mg Spinach juice concentrate (approx. 20-1) 50 mg
Alfalfa juice concentrate (approx. 20-1) 50 mg
Parsley juice concentrate (approx. 20-1) 50 mg
Artichoke juice concentrate (approx. 20-1) 70 mg
Carrot juice concentrate (approx. 20-1) 40 mg Cabbage juice concentrate (approx. 20-1) 60 mg Strawberry juice concentrate (approx. 20-1) 60 mg
Papaya juice concentrate (approx. 20-1) 60 mg
Apple juice concentrate (approx. 20-1) 60 mg
Ginkgo biloba component (1 lozenge) Ginkgo biloba extract (Westar Nutrition) 60 mg
Brown rice powder (carrier) 440 mg
Green barley component (1 lozenge)
Green barley juice concentrate 625 mg
Malt dextrin (carrier) 100 mg
EXAMPLE 3
The following composition falls within the first class of compositions of the present invention, and is in the form of a single lozenge for administration.
Multi -component lozenge A Ingredient Approximate
Amount
Vitamin A 3, 000 IU
Vitamin C 500 mg
Vitamin E 250 IU Selenium 70 μg
Folic acid 0. 1 mg
Thiamine (B-l) 0. 5 mg
Riboflavin 0. 5 mg
Niacin 7. 5 mg Vitamin B-6 1. 5 mg
Vitamin B-12 2. 15 mg
Biotin 0. 115 mg
Pantothenic acid 3. 0 mg
Calcium 250 mg Phosphorous 25 mg
Iodine 30 mg
Iron 5. 1 mg
Magnesium 50 mg
Copper 0. 5 mg Zinc 5 mg
Manganese 1. 25 mg
Barley juice concentrate (approx. 20-1) 580 mg
Spinach juice concentrate (approx. 20-1) 50 mg
Alfalfa juice concentrate (approx. 20-1) 50 mg Parsley juice concentrate (approx. 20-1) 50 mg
Artichoke juice concentrate (approx. 20-1 1]) 70 mg
Carrot juice concentrate (approx. 20-1) 40 mg
Cabbage juice concentrate (approx. 20-1) 60 mg
Strawberry juice concentrate (approx. 20- -1) 60 mg Papaya juice concentrate (approx. 20-1) 60 mg
Apple juice concentrate (approx. 20-1) 60 mg
Ginkgo biloba extract 60 mg
Malt dextrin 150 mg
EXAMPLE 4
The following composition falls within the first class of compositions of the present invention, and is in the form of a single lozenge for administration.
Multi-component lozenge B Ingredient Approximate
Amount
Vitamin A 14,000 IU
Vitamin C 530 mg
Vitamin E 170 IU Vitamin D 270 IU
Selenium 100 μg
Folic acid 0.2 mg
Thiamine (B-l) 1.7 mg
Riboflavin 3 mg Niacin 15 mg
Vitamin B-6 7 mg
Vitamin B-12 4.7 mg
Biotin 0.15 mg
Pantothenic acid 7.5 g Calcium 250 mg
Phosphorous 50 mg
Iodine 75 μg
Iron 9 mg
Magnesium 104 mg Copper 1 mg
Zinc 10 mg
Manganese 2.5 mg Molybdenum 50 μg Chromium 100 μg Choline 11 mg
Barley juice concentrate (approx. 20-1) 50 mg Spinach juice concentrate (approx. 20-1 ) 5 mg Alfalfa juice concentrate (approx. 20-1 ) 5 mg Parsley juice concentrate (approx. 20-1 ) 5 mg Artichoke juice concentrate (approx. 20 -1) 2 mg
Carrot juice concentrate (approx. 20-1) 1.5 mg Cabbage juice concentrate (approx. 20-1 ) 10 mg Strawberry juice concentrate (approx. 20-1) 2 mg Papaya juice concentrate (approx. 20-1) 2 mg Apple juice concentrate (approx. 20-1) 2 mg
Kiwi juice concentrate (approx. 20-1) 2 mg Acorn Squash juice concentrate (approx. 20-1)2 mg Grapefruit juice concentrate (approx. 20-1) 2 mg Celery juice concentrate (approx. 20-1) 2 mg Orange juice concentrate (approx. 20-1) 2 mg
Kale juice concentrate (approx. 20-1) 2 mg Tomato juice concentrate (approx. 20-1) 2 mg Lettuce juice concentrate (approx. 20-1 ) 2 mg Banana juice concentrate (approx. 20-1) 2 mg Ginkgo biloba extract 14 mg Maltodextrin 150 mg
EXAMPLE 5 A study was undertaken to evaluate the effect of the present invention on serum lipid profile, serum calcium levels, and serum sugar levels. The objectives of the study were to determine (1) whether oral intake of the composition results in increased levels of calcium ion in the human blood; (2) whether oral intake of the composition influences the levels of HDL in the lipid fraction distribution; and (3) whether oral intake of the composition influences the blood glucose levels.
A total of 50 subjects with ages between 45 and 65 years with abnormal lipid profiles were divided into 2 groups. One group (25 subjects) received placebo packages and ingested this twice a day, once in the morning and once in the evening. The other group (25 subjects) received a composition of the present invention which included two multi -vitamin lozenges, 1 antioxidant lozenge, 1 ginkgo biloba gelatin capsule, and 1 green barley lozenge, and ingested twice daily, once in the morning and once in the afternoon. The below-described results were compiled after a 2 month testing period. The identity of the lozenges was unknown by the subjects, and to the examiner (i.e., a double blind study) . Blood serum (approximately 4 cc) was collected at the starting time and again after the completion of two months of usage. A fasting lipid profile was conducted on the plasma samples using a lipid fractionation panel automated system [Hewlett-Packard Co.]. In addition, measurements of electrolytes (including
calcium ion) and glucose levels were made using the Chem 18 automated system [Hewlett-Packard Co . ] .
The results demonstrated (1) a statistically significant increase in the calcium ion levels for subjects using the first class of compositions of the present invention over those using the placebo (see Figure 1, showing the percentage increase in calcium over the placebo); (2) a statistically significant increase in the levels of HDL of about 35% was observed for subjects using the first class of compositions of the present invention over those using the placebo (see
Figure 2, showing the percentage increase in HDL over the placebo); and (3) a statistically significant decrease in the levels of glucose of about 22% was observed for subjects using the first class of compositions of the present invention over those using the placebo (see Figure 3, showing the percentage decrease in blood glucose over the placebo) .
EXAMPLE 6 The following composition falls within the second class of compositions of the present invention, and is in the form of a single lozenge for administration.
Ingredient Approximate
Amount
Vitamin A (from beta carotene) 5,000 IU
Vitamin C 500 mg Vitamin E 100 IU
Selenium 100 μg
Barley juice concentrate (approx. 20-1) 240 mg
Spinach juice concentrate (approx. 20-1) 250 mg
Alfalfa juice concentrate (approx. 20-1) 290 mg Parsley juice concentrate (approx. 20-1) 270 mg
Artichoke juice concentrate (approx. 20- 11)] 270 mg
Carrot juice concentrate (approx. 20-1) 260 mg
Cabbage juice concentrate (approx. 20-1] 260 mg
Strawberry juice concentrate (approx. 20 --1) 260 mg Papaya juice concentrate (approx. 20-1] 260 mg
EXAMPLE 7 The following composition falls within the second class of compositions of the present invention, and is in the form of a single lozenge for administration. Ingredient Approximate
Amount
Vitamin A (from beta carotene) 1 100,,01 30000 IU
Vitamin C 400 mg Vitamin E 200 IU Selenium 150 μg
Barley juice concentrate (approx. 20-1) 260 mg Spinach juice concentrate (approx. 20-1] 280 mg Alfalfa juice concentrate (approx. 20-1] 260 mg Parsley juice concentrate (approx. 20-1] 260 mg Artichoke juice concentrate (approx. 20-1 1]) 240 mg Carrot juice concentrate (approx. 20-1) 260 mg Cabbage juice concentrate (approx. 20-1) 250 mg Strawberry juice concentrate (approx. 20- -1) 250 mg Papaya juice concentrate (approx. 20-1) 260 mg
EXAMPLE 8
The following composition falls within the second class of compositions of the present invention, and is in the form of a single lozenge for administration.
Ingredient Approximate
Amount
Vitamin A (from beta carotene) 1100,, i0 00000 IU
Vitamin C 500 mg Vitamin E 250 IU
Selenium 100 μg
Barley juice concentrate (approx. 20-1) 280 mg
Spinach juice concentrate (approx. 20-1] 250 mg
Alfalfa juice concentrate (approx. 20-1] 250 mg Parsley juice concentrate (approx. 20-1] 270 mg
Artichoke juice concentrate (approx. 20- 1) 270 mg
Carrot juice concentrate (approx. 20-1) 260 mg
Cabbage juice concentrate (approx. 20-1] 260 mg
Strawberry juice concentrate (approx. 20 --1) 260 mg Papaya juice concentrate (approx. 20-1] 260 mg
EXAMPLE 9 The following composition falls within the second class of compositions of the present invention, and is in the form of a single lozenge for administration. Ingredient Approximate
Amount
Vitamin A (from beta carotene) 20,000 IU
Vitamin C 1, 000 mg
Vitamin E 250 IU Selenium 100 μg
Barley juice concentrate (approx. 20-1) 235 mg
Spinach juice concentrate (approx. 20-1) 250 mg
Alfalfa juice concentrate (approx. 20-1) 250 mg
Parsley juice concentrate (approx. 20-1) 275 mg Artichoke juice concentrate (approx. 20-1) 270 mg
Carrot juice concentrate (approx. 20-1) 260 mg
Cabbage juice concentrate (approx. 20-1) 260 mg Strawberry juice concentrate (approx. 20-1) 260 mg
Papaya juice concentrate (approx. 20-1) 260 mg
EXAMPLE 10
An experiment was undertaken to evaluate the effect of the second class of compositions on serum lipid profile, serum antioxidant levels, and plasma peroxide levels in normal healthy subjects. The objectives of the study were to determine whether oral administration of the second class of compositions of the present invention would result in: (a) an
increase in serum antioxidant levels; (b) an increase in the level of HDL; and (c) a reduction in serum levels of oxidants. A total of 10 healthy subjects between the ages of 19 and 23 years old were enrolled in a double blind cross over study. In the first arm of the study, half the subjects received antioxidant tablets and the other half received a placebo matched tablet containing mineral oil for 4 weeks. Subsequent to this 4 week first arm of the study, the subjects were taken off of all tablets for 4 weeks. Then, the second arm of the study began in which the subjects who were receiving the antioxidant tablets and those receiving the placebo from the first arm of the study switched.
Each subject took two tablets -- the first at 9:00 am and the second at 4:00 pm. There were no other dietary restrictions, bearing in mind that all subjects were college students and had a fair awareness of their diet content .
Each subject had blood drawn at three specific times: before the study commenced (as a baseline) ; at the end of the first arm of the study; and at the end of the second arm of the study. Blood samples were drawn at three different times of day during each period: 8:00 am (fasting levels, prior to the first dose); 12:00 pm (prior to lunch); and 4:00 pm (prior to dinner and to the second dose) .
Blood samples were then subjected to CBC analysis with differential electrolytes, liver function panel, and lipid fraction panel; peroxide level determination by horseradish peroxidase assay based on the method of Frew et al . , Anal . Chem. Acta, 155 : 139-150 (1983), and vitamin A and E level
determination by SmithKline Beecham Clinical Laboratories, Los
Angeles, CA.
The antioxidant tablets used were of the following composition : Ingredient Approximate
Amount
Vitamin A (from beta carotene) 2,500 IU
Vitamin C 250 mg
Vitamin E 50 IU Selenium 50 μg
Barley juice concentrate (approx. 20-1) 120 mg
Spinach juice concentrate (approx. 20-1) 125 mg
Alfalfa juice concentrate (approx. 20-1) 145 mg
Parsley juice concentrate (approx. 20-1) 135 mg Artichoke juice concentrate (approx. 20-1) 135 mg
Carrot juice concentrate (approx. 20-1) 130 mg
Cabbage juice concentrate (approx. 20-1) 130 mg
Strawberry juice concentrate (approx. 20-1) 130 mg
Papaya juice concentrate (approx. 20-1) 130 mg
Placebo tablets contained mineral oil. Each of these tablet were ingested twice daily as per the schedule described above.
Data are expressed as averages of groups compared to placebo with each individual acting as their own placebo (since each subject underwent both a test arm and placebo arm of the study) . Significance was determined using paired Student's t-test for all data except beta-carotene where unpaired Student's t-test was employed. For beta-carotene, data was collected from 5 subjects only in each arm of the study. The results demonstrated that at fasting levels, 80 percent of the subjects demonstrated a 10 percent reduction of total plasma oxidants at a 99 percent confidence level over placebo during intake of antioxidant vitamins. Measurements for oxidants obtained later during the day showed that only 50 and 60 percent of the subjects demonstrated a decrease for the
noon and 4:00 pm samples respectively, presumably because of interference of food substances absorbed and released into the plasma .
Ninety percent of the subjects showed a 19, 37, and 31 percent increase of vitamin E levels at confidence levels of 82, 99.9, and 99 percent for fasting, noon, and 4:00 pm samples respectively. This implies that endogenous vitamin E poll levels can be increased by antioxidant supplementation. Also, the relatively low fasting level is boosted after the 8:00 am dose by about 37 percent. This implies that the fasting level increase of 19 percent may have been lower if only the daily 8:00 am dosage was used.
Eighty percent of the subjects demonstrated a 46 percent increase in levels of beta-carotene at a 93 percent confidence level at 4:00 pm. However, this increase appeared to persist in only 20 percent of subjects at fasting and noon levels.
The maximum increase in vitamin A levels, 35 percent, was demonstrated at 4:00 pm with a 98 percent confidence level. The fasting and noon level increases were 14 and 11 percent for 50 and 30 percent of the subjects respectively.
Seventy percent of the subjects demonstrated a 48, 41, and 73 percent increase in serum HDL with a 97, 92, and 99.5 confidence level at fasting, noon, and 4:00 pm levels respectively. One subject outside of the study was followed for 1.5 years and continued to demonstrate a 50 percent increase in HDL levels while continuing oral intake of the antioxidants .
Clinical data presented in figures 4-8 demonstrate that those who took the daily dosage of the antioxidant composition described above compared to those taking the placebo have increased levels of vitamin A (see Fig. 4), increased levels of vitamin E (see Fig. 5) , increased levels of beta-carotene
(see Fig. 6) , decreased levels of oxidants in blood serum (see Fig. 7) , and increased levels of HDL (see Fig. 8) .
Numerous modifications and variations of the present invention are included in the above-identified specification and are expected to be obvious to one of skill in the art. It is also intended that the present invention cover modifications and variations of the compositions and methods for using them to accomplish their claimed uses within the scope of the appended claims and their equivalents.
Claims
1. A nutritional supplement comprising: an antioxidant component comprising approximately 1,000 IU to approximately 10,000 IU vitamin A, approximately 200 IU to approximately 500 IU vitamin E, approximately 100 mg to approximately 500 mg vitamin C, and approximately 5 μg to approximately 75 μg selenium, and a first juice concentrate, a green barley component comprising green barley extract, a ginkgo component comprising ginkgo biloba extract, and a multi -vitamin and mineral component.
2. The nutritional supplement of claim 1, wherein the first juice concentrate comprises a plurality of juice concentrates selected from the group consisting of acorn squash, alfalfa, apple, artichoke, avocado, bananas, broccoli, brussels sprouts, cabbage, cantaloupe, carrot, cauliflower, celery, collard greens, grapefruit, green leek, kale, kiwi fruit, lettuce, onion, papaya, parsley, potato, prune, spinach, strawberry, sweet potato, swiss chard, and tomato juice concentrates.
3. The nutritional supplement of claim 1, wherein the vitamin A, the vitamin E, the vitamin C, the selenium, and the first juice concentrate form two antioxidant lozenges, each lozenge having a preferred weight of between approximately 1,000 mg and approximately 2,000 mg .
4. The nutritional supplement of claim 3, wherein the total weight of the first juice concentrate is between approximately 30% to approximately 80% of the total weight of each antioxidant lozenge.
5. The nutritional supplement of claim 3, wherein the total weight of the combination of the vitamin C, the vitamin A, the vitamin E, and the selenium is between about 10% to about 50% of the total weight of each antioxidant lozenge.
6. The nutritional supplement of claim 3, wherein the first juice concentrate has a concentration of at least 10 times that of native juice in the unconcentrated form.
7. The nutritional supplement of claim 2, wherein each first juice concentrate selected from the group of juice concentrates comprises between about 5% to about 25% of the weight of the total juice concentrate.
8. The nutritional supplement of claim 1, wherein the multi -vitamin and mineral component comprises vitamins and minerals selected from the group consisting of vitamin A, vitamin C, vitamin D, vitamin E, folic acid, thiamine (B-l) , riboflavin, niacin, vitamin B-6, vitamin B-12, biotin, zinc, manganese, and selenium.
9. The nutritional supplement of claim 8, wherein the multi-vitamin and mineral component is derived from a non- juice source.
10. The nutritional supplement of claim 8, wherein the multi -vitamin and mineral component comprises a second juice concentrate is selected from the group consisting of: acorn squash, alfalfa, apple, artichoke, avocado, bananas, broccoli, brussels sprouts, cabbage, cantaloupe, carrot, cauliflower, celery, collard greens, grapefruit, green leek, green barley, kale, kiwi fruit, lettuce, onion, papaya, parsley, potato, prune, spinach, strawberry, sweet potato, swiss chard, and tomato juice concentrates.
11. The nutritional supplement of claim 9 or claim 10, wherein the multi-vitamin and mineral component forms two multi-vitamin and mineral lozenges.
12. The nutritional supplement of claim 11, wherein the preferred weight of each multi-vitamin and mineral lozenge is between approximately 750 mg to approximately 1,500 mg.
13. The nutritional supplement of claim 11, wherein the multi-vitamin and mineral component comprises second juice concentrates comprising between approximately 4% to approximately 25% of the total weight of the multi-vitamin and mineral lozenge.
14. The nutritional supplement of claim 11, wherein the multi -vitamin and mineral component comprises vitamins and minerals derived from a source other than from a juice concentrate and comprising about 10% to about 90% of the total weight of the multi-vitamin and mineral component.
15. The nutritional supplement of claim 11, wherein each multi -vitamin and mineral lozenge comprises an amount of vitamin A between about 1,000 IU to about 10,000 IU, an amount of vitamin C between about 10 mg to about 200 mg, an amount of vitamin D between about 10 IU to about 1,000 IU, an amount of vitamin E between about 5 IU to about 50 IU, an amount of folic acid between about 0.03 mg to about 1 mg, an amount of thiamine (B-l) between about 0.15 mg to about 0.75 mg, an amount of riboflavin between about 0.01 mg to about 5.0 mg, an amount of niacin between about 1.0 mg to 100 mg, an amount of vitamin B-6 between about 1.0 mg to about 10.0 mg, an amount of vitamin B-12 between about 1.0 mg to about 10.0 mg, an amount of biotin between about 0.10 mg to 1.00 mg, an amount of zinc between about 1.0 mg to about 10.0 mg, an amount of manganese between about 1.0 mg to about 10.0 mg, and an amount of selenium between about 5 μg to about 20 μg .
16. The nutritional supplement of claim 1, wherein the green barley extract component comprises, by weight percent, between approximately 60% to approximately 90% green barley juice concentrate.
17. The nutritional supplement of claim 16, wherein the green barley extract component forms one green barley extract lozenge .
18. The nutritional supplement of claim 17, wherein the weight of the green barley extract lozenge is approximately
600 mg to approximately 1,000 mg.
19. The nutritional supplement of claim 1, wherein the ginkgo biloba extract component comprises, by weight percent, approximately 5% to approximately 35% ginkgo biloba extract.
20. The nutritional supplement of claim 19, wherein the ginkgo biloba extract component forms one ginkgo biloba extract lozenge.
21. The nutritional supplement of claim 20, wherein the weight of the ginkgo biloba extract lozenge is from approximately 400 mg to approximately 750 mg .
22. A nutritional supplement comprising: two antioxidant lozenges, each comprising about 1,000 IU vitamin A, about 500 mg vitamin C, about 250 IU vitamin E, about 70 μg selenium, about 80 mg green barley juice concentrate (approx. 20-1) , about 50 mg spinach juice concentrate (approx. 20-1) , about 50 mg alfalfa juice concentrate (approx. 20-1), about 50 mg parsley juice concentrate (approx. 20-1) , about 70 mg artichoke juice concentrate (approx. 20-1), about 60 mg carrot
juice concentrate (approx. 20-1) , about 20 mg cabbage juice concentrate (approx. 20-1) , about 60 mg strawberry juice concentrate (approx. 20-1), and about 40 mg papaya juice concentrate (approx. 20-1); two multi-vitamin lozenges, each comprising about 2,000 IU vitamin A, about 25 mg vitamin C, about 15 IU vitamin E, about 5.3 μg selenium, about 0.1 mg folic acid, about 0.5 mg thiamine (B-l), about 0.5 mg riboflavin, about 7.5 mg niacin, about 1.5 mg vitamin B-6, about 2.15 mg vitamin B-12, about 0.115 mg biotin, about 3.0 mg pantothenic acid, about 250 mg calcium, about 25 mg phosphorous, about 30 mg iodine, about 5.1 mg iron, about 50 mg magnesium, about 0.5 mg copper, about 5.0 mg zinc, about 1.25 mg manganese, about 80 mg green barley juice concentrate (approx. 20-1), about 50 mg spinach juice concentrate (approx. 20-1), about 50 mg alfalfa juice concentrate (approx. 20-1), about 50 mg parsley juice concentrate (approx. 20-1), about 70 mg artichoke juice concentrate (approx. 20-1) , about 40 mg carrot juice concentrate (approx. 20-1), about 60 mg cabbage juice concentrate (approx. 20-1) , about 60 mg strawberry juice concentrate (approx. 20-1) , about 60 mg papaya juice concentrate (approx. 20-1) , and about 60 mg apple juice concentrate (approx. 20-1) ; a ginkgo biloba lozenge comprising about 60 mg ginkgo biloba extract [Westar Nutrition] and about 440 g Brown rice powder; and a green barley lozenge comprising about 600 mg green barley juice concentrate and 150 mg malt dextrin.
23. A nutritional supplement comprising: two antioxidant lozenges, each comprising about 1,000 IU vitamin A, about 500 mg vitamin C, about 250 IU vitamin E, about 100 μg selenium, about 20 mg green barley juice concentrate (approx. 20-1) , about 50 mg spinach juice concentrate (approx. 20-1) , about 50 mg alfalfa juice concentrate (approx. 20-1) , about 70 mg parsley juice concentrate (approx. 20-1) , about 70 mg artichoke juice concentrate (approx. 20-1) , about 60 mg carrot juice concentrate (approx. 20-1) , about 20 mg cabbage juice concentrate (approx. 20-1) , about 60 mg strawberry juice concentrate (approx. 20-1) , and about 40 mg papaya juice concentrate (approx. 20-1); two multi-vitamin lozenges, each comprising about 2,000 IU vitamin A, about 25 mg vitamin C, about 15 IU vitamin E, about 5.3 μg selenium, about 0.1 mg folic acid, about 0.5 mg thiamine (B-l), about 0.5 mg riboflavin, about 7.5 mg niacin, about 1.5 mg vitamin B-6, about 2.15 mg vitamin B-12, about 0.115 mg biotin, about 3.0 mg pantothenic acid, about 250 mg calcium, about 25 mg phosphorous, about 30 mg iodine, about 5.1 mg iron, about 50 mg magnesium, about 0.5 mg copper, about 5.0 mg zinc, about
1.25 mg manganese, about 80 mg green barley juice concentrate (approx. 20-1), about 50 mg spinach juice concentrate (approx. 20-1), about 50 mg alfalfa juice concentrate (approx. 20-1), about 50 mg parsley juice concentrate (approx. 20-1) , about 70 mg artichoke juice concentrate (approx. 20-1) , about 40 mg carrot juice concentrate (approx. 20-1), about 60 mg cabbage juice concentrate (approx. 20-1) , about 60 mg strawberry juice concentrate (approx. 20-1) , about 60 mg papaya juice
concentrate (approx. 20-1), and about 60 mg apple juice concentrate (approx. 20-1); a ginkgo biloba lozenge comprising about 60 mg ginkgo biloba extract [Westar Nutrition] and about 440 mg brown rice powder; and a green barley lozenge comprising about 625 mg green barley juice concentrate and 100 mg malt dextrin.
24. A nutritional supplement comprising: an antioxidant component comprising about 3,000 IU vitamin A, about 500 mg vitamin C, about 250 IU vitamin E, about 70 μg selenium, about 50 mg spinach juice concentrate (approx. 20-1), about 50 mg alfalfa juice concentrate (approx. 20-1), about 50 mg parsley juice concentrate (approx. 20-1) , about 70 mg artichoke juice concentrate (approx. 20-1) , about 40 mg carrot juice concentrate (approx. 20-1) , about 60 mg cabbage juice concentrate (approx. 20-1), about 60 mg strawberry juice concentrate (approx. 20-1) , about 60 mg papaya juice concentrate (approx. 20-1) , and about 60 mg apple juice concentrate (approx. 20-1); a multi-vitamin and mineral component comprising about 0.1 mg folic acid, about 0.5 mg thiamine (B-l), about 0.5 mg riboflavin, about 7.5 mg niacin, about 1.5 mg vitamin B-6, about 2.15 mg vitamin B-12, about 0.115 mg biotin, about 3.0 mg pantothenic acid, about 250 mg calcium, about 25 mg phosphorous, about 30 mg iodine, about 5.1 mg iron, about 50 mg magnesium, about 0.5 mg copper, about 5.0 mg zinc, and about 1.25 mg manganese; a green barley component comprising about 580 mg green barley juice concentrate (approx. 20-1) ; and a ginkgo biloba extract
component comprising about 60 mg ginkgo biloba extract [Westar Nutrition] and about 150 mg malt dextrin.
25. A nutritional supplement comprising: an antioxidant component comprising about 14,000 IU vitamin A, about 530 mg vitamin C, about 170 IU vitamin E, about 270 IU vitamin D, about 100 μg selenium, about 5 mg spinach juice concentrate (approx. 20-1), about 5 mg alfalfa juice concentrate (approx. 20-1) , about 5 mg parsley juice concentrate (approx. 20-1) , about 2 mg artichoke juice concentrate (approx. 20-1), about 1.5 mg carrot juice concentrate (approx. 20-1), about 10 mg cabbage juice concentrate (approx. 20-1) , about 2 mg strawberry juice concentrate (approx. 20-1) , about 2 mg papaya juice concentrate (approx. 20-1) , about 2 mg apple juice concentrate (approx. 20-1), about 2 mg kiwi juice concentrate (approx. 20-1) , about 2 mg acorn squash juice concentrate (approx. 20-1) , about 2 mg grapefruit juice concentrate (approx. 20-1) , about 2 mg celery juice concentrate (approx. 20-1) , about 2 mg orange juice concentrate (approx. 20-1) , about 2 mg kale juice concentrate (approx. 20-1) , about 2 mg tomato juice concentrate (approx. 20-1) , about 2 mg lettuce juice concentrate (approx. 20-1), and about 2 mg banana juice concentrate (approx. 20-1) ; a multi-vitamin and mineral component comprising about 0.2 mg folic acid, about 1.7 mg thiamine (B-l) , about 3 mg riboflavin, about 15 mg niacin, about 7 mg vitamin B-6, about 4.7 mg vitamin B-12, about 0.15 mg biotin, about 7.5 mg pantothenic acid, about 250 mg calcium, about 50 mg phosphorous, about 75 μg iodine, about
9 mg iron, about 104 mg magnesium, about 1 mg copper, about 10 mg zinc, and about 2.5 mg manganese; a green barley component comprising about 50 mg green barley juice concentrate (approx. 20-1) ; and a ginkgo biloba extract component comprising about 14 mg ginkgo biloba extract [Westar Nutrition] , about 150 mg maltodextrin, about 50 μg molybdenum, about 100 μg chromium, and about 11 mg choline.
26. A method for preparing the nutritional supplement of claim 1 or claim 25, comprising admixing the components with a suitable carrier.
27. A method of increasing levels of high density lipoprotein (HDL) in human blood plasma comprising administering daily the nutritional supplement of claim 1, claim 22, claim 23, claim 24, or claim 25.
28. A method of decreasing the concentration of free radicals in human blood plasma comprising administering daily the nutritional supplement of claim 1, claim 22, claim 23, claim 24, or claim 25.
29. A method of decreasing blood glucose levels comprising administering daily the nutritional supplement of claim 1, claim 22, claim 23, claim 24, or claim 25.
30. A method of increasing calcium ion concentration in human blood plasma comprising administering daily the
nutritional supplement of claim 1, claim 22, claim 23, claim 24 , or claim 25.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU35825/97A AU3582597A (en) | 1996-06-28 | 1997-06-27 | Nutritional supplement composition and use |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67175596A | 1996-06-28 | 1996-06-28 | |
| US08/671,755 | 1996-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1998000024A1 true WO1998000024A1 (en) | 1998-01-08 |
Family
ID=24695757
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1997/011243 WO1998000024A1 (en) | 1996-06-28 | 1997-06-27 | Nutritional supplement composition and use |
| PCT/US1997/011659 WO1998000026A1 (en) | 1996-06-28 | 1997-06-30 | Nutritional supplement composition and use |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1997/011659 WO1998000026A1 (en) | 1996-06-28 | 1997-06-30 | Nutritional supplement composition and use |
Country Status (2)
| Country | Link |
|---|---|
| AU (2) | AU3582597A (en) |
| WO (2) | WO1998000024A1 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0951844A2 (en) * | 1998-04-22 | 1999-10-27 | Hans-Günter Berner | Energy-drink based on fruit juices |
| WO2002024002A2 (en) * | 2000-09-22 | 2002-03-28 | Mars Uk Limited | Food supplement |
| US6488957B1 (en) | 2001-12-17 | 2002-12-03 | Teddy A. Koumarianos | Food additive composition |
| FR2827518A1 (en) * | 2001-07-17 | 2003-01-24 | Sod Conseils Rech Applic | Use of Ginkgo biloba extract containing flavone glycosides and/or ginkgolides for prevention and treatment of muscle wasting in elderly |
| WO2004026287A1 (en) * | 2002-09-09 | 2004-04-01 | Nestec S.A. | Orally administrable composition for improving skin quality |
| FR2847426A1 (en) * | 2002-11-22 | 2004-05-28 | Jean Morelle | Use of fruit and vegetable extracts with peroxidase- and catalase-like ability to destroy hydrogen peroxide as dietary supplements, for skin protection and to prepare cosmetic, dermatological and veterinary products |
| WO2004047633A1 (en) * | 2002-11-25 | 2004-06-10 | Harry Louis Platt | Combined wrist blood pressure and ecg monitor |
| DE102005039542A1 (en) * | 2005-08-22 | 2007-03-22 | Helmut Sell | Health/vitalizing drink combination, useful for hydrotherapeutic improvement of the body's cellular metabolism, comprises diluted iodized brine as water, natural apple juice, natural bio materials as additives |
| EP1982604A1 (en) * | 2007-04-20 | 2008-10-22 | Naturheilzentrum Allgäu | Dietary supplement for compensating for a lack of nutrients |
| US20080316996A1 (en) * | 2007-06-22 | 2008-12-25 | Edward Hatala | Controlling timing of synchronization updates |
| US8124135B2 (en) | 2005-05-24 | 2012-02-28 | Vdf Futureceuticals, Inc. | Compositions and methods for reduction of LDL oxidation |
| CN104041766A (en) * | 2014-06-24 | 2014-09-17 | 恩施州益寿果业股份有限公司 | Se-enriched kiwi fruit buccal tablets and preparation method of Se-enriched kiwi fruit buccal tablets |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4753816A (en) * | 1987-05-20 | 1988-06-28 | Nabisco Brands, Inc. | Fruit juice based hard candy |
| US5290605A (en) * | 1989-06-29 | 1994-03-01 | Niva Shapira | Sun-exposure nutritional supporting composition |
| US5571441A (en) * | 1994-11-01 | 1996-11-05 | The Procter & Gamble Company | Nutrient supplement compositions providing physiologic feedback |
-
1997
- 1997-06-27 WO PCT/US1997/011243 patent/WO1998000024A1/en active Application Filing
- 1997-06-27 AU AU35825/97A patent/AU3582597A/en not_active Abandoned
- 1997-06-30 WO PCT/US1997/011659 patent/WO1998000026A1/en active Application Filing
- 1997-06-30 AU AU36498/97A patent/AU3649897A/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4753816A (en) * | 1987-05-20 | 1988-06-28 | Nabisco Brands, Inc. | Fruit juice based hard candy |
| US5290605A (en) * | 1989-06-29 | 1994-03-01 | Niva Shapira | Sun-exposure nutritional supporting composition |
| US5571441A (en) * | 1994-11-01 | 1996-11-05 | The Procter & Gamble Company | Nutrient supplement compositions providing physiologic feedback |
Cited By (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0951844A3 (en) * | 1998-04-22 | 2000-05-24 | Hans-Günter Berner | Energy-drink based on fruit juices |
| EP0951844A2 (en) * | 1998-04-22 | 1999-10-27 | Hans-Günter Berner | Energy-drink based on fruit juices |
| WO2002024002A2 (en) * | 2000-09-22 | 2002-03-28 | Mars Uk Limited | Food supplement |
| WO2002024002A3 (en) * | 2000-09-22 | 2002-08-22 | Mars Uk Ltd | Food supplement |
| US7138148B2 (en) | 2001-07-17 | 2006-11-21 | Societe De Conseils De Recherches Et D'applications Scientifiques (Scras) | Use of extracts of Ginkgo biloba for preparing a medicament intended to treat sarcopenia |
| FR2827518A1 (en) * | 2001-07-17 | 2003-01-24 | Sod Conseils Rech Applic | Use of Ginkgo biloba extract containing flavone glycosides and/or ginkgolides for prevention and treatment of muscle wasting in elderly |
| WO2003007973A1 (en) * | 2001-07-17 | 2003-01-30 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia |
| KR100891393B1 (en) * | 2001-07-17 | 2009-04-02 | 소시에떼 드 꽁세이으 드 르세르세 에 따블리까시옹 시앙띠피끄 (에스.세.에르.아.에스.) | Use of Ginkgo Biloba Extracts for Preparing a Medicine for Treating Sarcopenia |
| US6488957B1 (en) | 2001-12-17 | 2002-12-03 | Teddy A. Koumarianos | Food additive composition |
| US6558691B1 (en) | 2001-12-17 | 2003-05-06 | Teddy A. Koumarianos | Food additive composition |
| WO2004026287A1 (en) * | 2002-09-09 | 2004-04-01 | Nestec S.A. | Orally administrable composition for improving skin quality |
| WO2004047563A1 (en) * | 2002-11-22 | 2004-06-10 | Jean Morelle | Use of food plants for their hydrogen peroxide destroying activity |
| FR2847426A1 (en) * | 2002-11-22 | 2004-05-28 | Jean Morelle | Use of fruit and vegetable extracts with peroxidase- and catalase-like ability to destroy hydrogen peroxide as dietary supplements, for skin protection and to prepare cosmetic, dermatological and veterinary products |
| WO2004047633A1 (en) * | 2002-11-25 | 2004-06-10 | Harry Louis Platt | Combined wrist blood pressure and ecg monitor |
| US8124135B2 (en) | 2005-05-24 | 2012-02-28 | Vdf Futureceuticals, Inc. | Compositions and methods for reduction of LDL oxidation |
| DE102005039542A1 (en) * | 2005-08-22 | 2007-03-22 | Helmut Sell | Health/vitalizing drink combination, useful for hydrotherapeutic improvement of the body's cellular metabolism, comprises diluted iodized brine as water, natural apple juice, natural bio materials as additives |
| EP1982604A1 (en) * | 2007-04-20 | 2008-10-22 | Naturheilzentrum Allgäu | Dietary supplement for compensating for a lack of nutrients |
| US20080316996A1 (en) * | 2007-06-22 | 2008-12-25 | Edward Hatala | Controlling timing of synchronization updates |
| CN104041766A (en) * | 2014-06-24 | 2014-09-17 | 恩施州益寿果业股份有限公司 | Se-enriched kiwi fruit buccal tablets and preparation method of Se-enriched kiwi fruit buccal tablets |
| CN104041766B (en) * | 2014-06-24 | 2016-07-06 | 恩施州益寿果业股份有限公司 | A kind of selenium rich kiwi fruit buccal tablet and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| AU3582597A (en) | 1998-01-21 |
| WO1998000026A1 (en) | 1998-01-08 |
| AU3649897A (en) | 1998-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5976548A (en) | Nutritional supplement composition and use | |
| US6054128A (en) | Dietary supplements for the cardiovascular system | |
| Eliseeva et al. | Vitamin C (ascorbic acid)–description, benefits and where it is found | |
| US6326031B1 (en) | Method of decreasing cholesterol and triglycerides levels with a composition containing fish oil, garlic, rutin, and capsaicin | |
| US6440464B1 (en) | Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates | |
| US6562869B1 (en) | Nutritional supplement for increased energy and stamina | |
| US6511675B2 (en) | Composition and method for correcting a dietary phytochemical deficiency | |
| US20070026108A1 (en) | Nutritional supplement drink containing xanthone extracts | |
| US20080003278A1 (en) | Food products and dietary supplements for improving mental performance | |
| US20030143311A1 (en) | Recovery drink formula and method | |
| ZA200104738B (en) | Composition for optimizing muscle performance during exercise. | |
| Thiel | Natural vitamins may be superior to synthetic ones | |
| WO1998000024A1 (en) | Nutritional supplement composition and use | |
| RU2172630C2 (en) | Association in the form of food additive or drug and method of treating man and animals utilizing it (options) | |
| US7438936B2 (en) | Dietary supplement and related method | |
| US20050287131A1 (en) | Health supplement | |
| US20160278417A1 (en) | Nutritionally Enhanced Fraction From Rice Bran And Method of Lowering Insulin Resistance Using Same | |
| Rivlin | Vitamin Defi ciencies | |
| WO1997033599A1 (en) | Fish oil and garlic nutritive composition | |
| Padh | Vitamins for optimal health | |
| RU2033732C1 (en) | Foodstuff | |
| Wahlqvist et al. | Vitamins, vitamin-like compounds and phytonutrients | |
| Sriram et al. | 8 Micronutrient and Antioxidant Therapy in Critically Ill Patients | |
| Zeng | Effects of dietary strategies on reactive oxygen species production | |
| WO2024022778A1 (en) | Combination product comprising active substances suitable for adult requirements |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 98504328 Format of ref document f/p: F |
|
| 122 | Ep: pct application non-entry in european phase |